





Understanding metabolic robustness of  






zur Erlangung des Grades eines 
Doktor der Naturwissenschaften 
(Dr. rer.nat.) 








Aus Mailand, Italien 
 











Dieses Werk bzw. Inhalt steht unter einer Creative Commons Namensnennung 
Keine kommerzielle Nutzung Weitergabe unter gleichen Bedingungen 3.0 
Deutschland Lizenz. 
 

























Die vorliegende Arbeit wurde in der Zeit von Oktober 2016 bis Juli 2020 unter der Betreuung 

















Erstgutachter:  Dr. Hannes Link   
Zweitgutachter:  Prof. Lennart Randau 
Weitere Mitglieder der Prüfungskommission:  Prof. Victor Sourjik 






















































Stefano Donati, Timur Sander, Hannes Link. Crosstalk between transcription and metabolism: 






Nicht veröffentlichte Arbeiten: 
 
Stefano Donati, Michelle Kuntz, Vanessa Pahl, Dominik Beuter, Timo Glatter, José Vicente 
Gomes Filho, Lennart Randau, Hannes Link. The metabolome buffers CRISPRi-knockdowns of 
enzymes in E. coli metabolism. Under review, Cell Systems. 
 
Dušica Radoš, Stefano Donati, Martin Lempp, Hannes Link. Homeostasis of the Escherichia coli 




























































































































Table of Contents 
 
Table of Contents ...................................................................................................................... I 
List of Figures ...........................................................................................................................III 
List of Supplementary Figures ................................................................................................. IV 
List of Supplementary Tables .................................................................................................. IV 
Abbreviations .......................................................................................................................... V 
Summary ................................................................................................................................ VI 
Zusammenfassung ................................................................................................................. VII 
1 - Introduction .........................................................................................................................1 
1.1 - Crosstalk between transcription and metabolism: how much enzyme is enough for a 
cell? ......................................................................................................................................1 
1.1.1 - Metabolomics and transcriptomics studies indicate extensive crosstalk..................3 
1.1.2 - Information flow from transcription to metabolism ................................................4 
1.1.3 - Information flow from metabolism to transcription ................................................5 
1.1.4 - Inference of cross-talk from multi-omics data .........................................................7 
1.1.5 - Crosstalk regulates enzyme levels ......................................................................... 10 
1.1.6 – Discussion ............................................................................................................ 13 
1.2 - Mass spectrometry-based methods for systems biology studies .................................. 15 
1.3 - CRISPR interference, a tool for the control of gene expression .................................... 18 
2 – Characterization of CRISPRi-knockdowns of metabolic genes ............................................ 21 
2.1 - Results ........................................................................................................................ 21 
2.1.1 - Comparison of different CRISPRi systems .............................................................. 21 
2.1.2 - Screening of an arrayed library of CRISPRi strains ................................................. 22 
2.1.3 - Proteomics-based characterization of CRISPRi strains ........................................... 25 
2.2 - Discussion ................................................................................................................... 29 
3 - The metabolome buffers CRISPRi-knockdowns of enzymes in E. coli metabolism ............... 31 
3.1 - Results ........................................................................................................................ 31 
3.1.1 - An inducible CRISPRi system identifies rate-limiting enzymes ............................... 31 
3.1.2 - E. coli metabolism is robust against CRISPRi-knockdowns of enzymes ................... 33 
3.1.3 - CRISPRi achieves similar and specific decreases of enzyme-levels ......................... 36 
3.1.4 - Substrates and allosteric effectors buffer decreases of enzyme-levels .................. 38 
3.1.5 - Metabolites cause a compensatory upregulation of enzymes in the target-pathway
 ....................................................................................................................................... 41 
3.1.6 - 6-phosphogluconate buffers knockdowns in the pentose-phosphate pathway ..... 45 
3.2 - Discussion ................................................................................................................... 47 
 
 II   
4 - Homeostasis of the Escherichia coli biosynthetic metabolome across different environments
 ............................................................................................................................................... 49 
4.1 - Results ........................................................................................................................ 49 
4.1.1 - A comprehensive and systematic dataset of the E. coli metabolome .................... 49 
4.1.2 - The metabolome of growing cells is independent from growth effects ................. 50 
4.1.3 - Homeostasis of amino acid metabolism ................................................................ 52 
4.1.4 - Nucleotide levels remain stable despite environmental or genetic perturbations . 55 
4.2 - Discussion ................................................................................................................... 58 
5 - Conclusion and Outlook ..................................................................................................... 61 
6 - Materials and Methods ...................................................................................................... 65 
6.1 - Construction and cultivation of CRISPRi strains ............................................................ 65 
6.1.1 - Construction of arrayed strains ............................................................................. 65 
6.1.2 - Construction of the CRISPRi pooled library ........................................................... 66 
6.1.3 - Media ................................................................................................................... 66 
6.1.4 - General Cultivation conditions .............................................................................. 67 
6.1.5 - Cultivation conditions for OD and YPet-, GFP-fluorescence measurements ........... 67 
6.1.6 - Cultivation conditions for metabolome and proteome sampling ........................... 68 
6.1.7 - Cultivation conditions of the pooled CRISPRi library.............................................. 68 
6.2 - Cultivation of E. coli under different environmental conditions ................................... 69 
6.2.1 - Strains and growth conditions .............................................................................. 69 
6.2.2 - Cultivation and growth rates ................................................................................ 70 
6.2.3 - Sampling and sample preparation for metabolomics ............................................ 70 
6.2.4 - Next Generation Sequencing and Data Analysis .................................................... 71 
6.3 - Metabolomics measurements ..................................................................................... 72 
6.4 - Proteomics sample preparation and measurement ..................................................... 73 
6.5 - Data analysis ............................................................................................................... 75 
6.5.1 - Quantification and Statistical Analysis .................................................................. 75 
6.5.2 - Constraint-based modelling .................................................................................. 75 
6.5.3 - Singular value decomposition ............................................................................... 75 
Supplementary Materials ........................................................................................................ 77 
References ............................................................................................................................ 109 
Acknowledgments ................................................................................................................ 117 
Declaration of Contributions ................................................................................................. 119 






List of Figures 
 
Figure 1: Schematic of the cellular processes that are involved in crosstalk between 
transcription and metabolism 
2 
Figure 2: Robust versus efficient enzyme levels. 9 
Figure 3: Scheme of a MS-based multi-omics workflow. 18 
Figure 4: Scheme of CRISPRi components and mechanism. 20 
Figure 5: Comparison of different CRISPRi systems. 22 
Figure 6: Growth screening of an arrayed CRISPRi library of 110 strains. 24 
Figure 7: Characterization of 4 CRISPRi strains. 28 
Figure 8: Dynamic knockdowns of enzymes with CRISPR interference. 32 
Figure 9: Dynamic knockdowns of 1513 genes in the metabolic network of E. coli. 35 
Figure 10: Growth defects and abundances of target-enzymes in 30 CRISPRi strains. 37 
Figure 11: Metabolome of 30 CRISPRi strains and dynamic metabolite responses. 40 
Figure 12: Localized proteome changes occur in CRISPRi strains with a growth defect. 44 
Figure 13: 6-phosphogluconate coordinates the Entner-Doudoroff pathway with the 
Pentose-Phosphate pathway. 
46 
Figure 14: General overview of the experiments and data quality assessment. 50 
Figure 15: Analysis of the metabolome dataset and comparison with the matching 
proteome dataset from Schmidt et al. 2016. 
51 
Figure 16: Amino acid pools in E. coli. 54 
Figure 17: Nucleotide levels in E. coli. 57 















 IV   
 
List of Supplementary Figures 
 
Figure S1: Behaviour of a YYdCas9 strain with interference of ftsZ, in comparison to 
the YYdCas9 control strain. 
77 
Figure S2: Differences in proteome data when normalizing for fold-change against 
different conditions. 
78 
Figure S3: Details of the raw deep-sequencing data. 79 
Figure S4: Fold-changes of sgRNA abundances in the two competition experiments. 80 
Figure S5: Related to Figure 10. 81 
Figure S6: Related to Figure 10.  82 
Figure S7: Related to Figure 11.  82 
Figure S8: Similarity between the differentially expressed proteins of the 30 measured 
proteomes 
83 
Figure S9: Related to Figure 12.  84 
Figure S10: Related to Figure 12. 90 
Figure S11: Agglomerative hierarchical clustering of the condition-dependent 
metabolome dataset. 
91 
Figure S12: Comparison of absolute intracellular concentrations of metabolites with 
literature data. 
93 
Figure S13: Comparison of growth rates for conditions analyzed both in our study and 
in Schmidt ed al. 2016. 
93 
Figure S14: Metabolites with the highest correlation between their concentrations 
and growth rates. 
94 
Figure S15: Histogram representing correlation values between metabolite levels 
against the relative growth rate, data from Kochanowski et al. 2016. 
94 
Figure S16: Correlations between relative standard deviation (RSD) of amino-acids 95 
Figure S17: Calibration curves for absolute metabolite concentration calculations. 96 
 
List of Supplementary Tables 
 
Table S1: Bacterial strains and identification sequence for the arrayed CRISPRi library. 99 
Table S2: Occurrence of growth phenotypes at different starting optical densities 
(ODs). 
103 
Table S3: Correlation between metabolite concentrations and growth rates in 
different environmental conditions. 
103 
Table S4: SVD of the metabolomics and proteomics datasets. 104 
Table S5: Strains and reagents. 105 








Δ  gene deletion  
% (v/v)  percent per volume  
% (w/v)  percent per volume  
Amp  Ampicillin  
aTc Anhydrotetracycline 
ATP  Adenosine triphosphate  
bp  basepairs  
Cas protein CRISPR associted protein 
Cmp  Chloramphenicol  
CRISPR  Clustered Regulary Interspaced Short Palindromic Repeats  
CRISPRi CRISPR interference 
DMSO  dimethyl sulfoxide  
DNA  deoxyribonucleic acid  
dNTP  deoxyribonucleoside triphosphate  
dsDNA  Doublestranded DNA  
et al.  et alii, and others  
FBA Flux balance analysis 
g  gramm  
GFP  Green gluorescent protein  
h  Hours  
IPTG  Isopropyl β-D-1-thiogalactopyranoside  
Km  Kanamycin  
Kb  Kilobases  
L  Liter  
LB medium  Lysogeny broth medium  
LC Liquid chromatography 
Ln Natural logarithm 
Log2 Binary logarithm 
M  Molar (mol/L)  
min  Minutes  
mRNA  Messenger RNA  
MS Mass spectrometry 
MS/MS Tandem mass spectrometry 
μ  Micro (10-6)  
n  Nano (10-9)  
N-terminal  Amino-terminal  
nt  Nucleotides  
OD600nm  Optical density at 600 nm  
PAM Protospacer adjacent motive 
PCR  Polymerase chain reaction  
pH  Potential of hydrogen  
RNA Ribonucleic acid 
rpm  Revolutions per minute  
RSD Relative standard deviation 
s  Seconds  
sgRNA Single guide RNA 
SVD Singular value decomposition 
Τ Tau, response time 





 VI   
Summary 
 
Metabolism provides the essential biochemical intermediates and energy that enable life and 
its growth. In this thesis we studied robustness of Escherichia coli metabolism, by perturbing it 
with different methods and measuring the response at a molecular level. 
 
In Chapter 1, we introduce the latest insight into metabolic regulation and optimality in 
microbial model organisms. Overall, we identified and described two major gaps in knowledge: 
the limited amount of known metabolite-protein interactions and the unknown objectives 
towards which cells optimize their enzyme levels. Moreover, we provide a short introduction to 
the relevant methods utilized in this thesis. 
 
In Chapter 2, we describe a series of experiments which confirmed that CRISPRi is a reliable tool 
to specifically perturb metabolism in E. coli. We showcase the advantage of using a CRISPRi 
system integrated in the genome, which is suitable to apply inducible knockdowns of essential 
genes. We demonstrate this by characterizing growth for a library of over 100 strains and 
verifying inducibility and specificity with proteomics data. 
 
In Chapter 3 we applied the validated CRISPRi setup to perturb and study metabolism 
systematically. First, we used a pooled CRISPRi library to knock down all metabolic genes in E. 
coli. By following the appearance of growth defects with next generation sequencing, we show 
that metabolic enzymes are expressed at higher levels than strictly necessary. We then focused 
on a panel of 30 CRISPRi strains and characterize their response to lower enzyme levels with 
metabolomics and proteomics. We show that the metabolome can buffer perturbations of 
enzyme levels in two different stages: first, metabolites increase enzyme activity to maintain 
optimal growth and only later they activate gene regulatory feedbacks to specifically upregulate 
perturbed pathways. 
 
In Chapter 4 we employed a different approach to perturb bacterial metabolism, by growing E. 
coli in different environmental conditions and measuring the response at the metabolome level. 
We could show that in exponentially growing cells key biosynthetic products as amino acids and 
nucleotides are kept at relatively stable levels across different environments. We compared our 
dataset to a matching published proteomics dataset, showing that unlike the proteome, 








Der Stoffwechsel, oder auch Metabolismus, stellt die essentiellen Bausteine und die Energie 
bereit, die Leben und zelluläres Wachstum voraussetzen. In dieser Doktorarbeit wurde die 
Robustheit des Metabolismus von Escherichia coli untersucht, indem er mit verschiedenen 
Methoden perturbiert und die zelluläre Antwort auf molekularer Ebene verfolgt wurde.  
In Kapitel 1 werden die neuesten Erkenntnisse über die Regulation und Optimalität des 
Metabolismus in mikrobiellen Modellorganismen betrachtet. Zusammenfassend ließen sich 
zwei große Probleme feststellen: Zum einen die niedrige Zahl an nachgewiesenen Metabolit-
Protein Interaktionen und zum anderen die unbekannten Ziele, auf deren Grundlage Bakterien 
ihre Enzymlevel regulieren und einstellen. Darüber hinaus werden in diesem Kapitel die für diese 
Arbeit relevanten und verwendeten Methoden besprochen.  
In Kapitel 2 werden eine Reihe von Experimenten beschrieben, die bestätigen, dass CRISPRi eine 
zuverlässige Methode ist, um den Metabolismus in E. coli spezifisch zu perturbieren. Außerdem 
werden die Vorteile von einem genomisch integriertem CRISPRi-System gezeigt, das dazu 
verwendet werden kann die Expression von essentiellen Genen induzierbar zu reprimieren. Die 
Induzierbarkeit und Spezifität konnten durch ein Wachstumsscreening von 100 Stämmen und 
Proteom-Analysen belegt werden. 
In Kapitel 3 wird dargestellt, wie das im vorherigen Kapitel beschriebene CRISPRi- System 
verwendet wurde, um den Metabolismus systematisch zu perturbieren und zu untersuchen. 
Zunächst wurde das Wachstum von Stämmen in einer gepoolten CRISPRi-Library, welche alle 
Gene im zentralen Stoffwechsel von E. coli beinhaltete, mittels Next-Generation Sequencing 
verfolgt. Hierbei konnte gezeigt werden, dass Enzyme im zentralen Metabolismus in höheren 
Mengen von der Zelle hergestellt werden, als es für die Aufrechterhaltung des Wachstums nötig 
wäre. Es wurden 30 CRISPRi Stämme mit Hilfe von Metabolomics und Proteomics genauer 
untersucht, um die zelluläre Antwort auf niedrigere Enzymlevel zu studieren. Hierbei konnte 
festgestellt werden, dass das Metabolom die Störung von Enzymleveln auf zwei unterschiedliche 
Wege puffern kann. Zunächst erhöhen Metabolite die Aktivität von Enzymen, um optimales 
Wachstum zu gewährleisten, und erst später aktivieren sie genregulatorische Feedback-
Mechanismen, um perturbierte Stoffwechselwege spezifisch hochzuregulieren. 
In Kapitel 4 wird geschildert, wie eine alternative Methode, nämlich das Wachstum unter 
verschiedenen Bedingungen, genutzt wurde, um den Metabolismus zu perturbieren und 
anschließend die metabolische Antwort zu bestimmen. Hierbei konnte gezeigt werden, dass in 
exponentiell wachsenden Zellen unter verschiedenen Wachstumsbedingungen die 
Konzentrationen von Schlüsselbausteinen, wie Aminosäuren und Nukleotiden, stabil gehalten 
werden. Diese Daten wurden zudem mit einem passenden, bereits publizierten Proteomics 
Datensatz verglichen und es konnte gezeigt werden, dass Metabolitkonzentrationen, im 






















1 - Introduction 
 
1 
1 - Introduction 
 
1.1 - Crosstalk between transcription and metabolism: how 
much enzyme is enough for a cell? 
 
The function and structure of metabolic and transcriptional networks are well 
characterized. Transcription is the first step in the control of gene expression. 
Metabolism governs the supply of energy and cellular building blocks. Besides regulatory 
interactions within each of the two networks, mutual feedback is abundant between 
them. Already in the 1950s the discovery of the lac operon showed that transcription 
impacts metabolic operation (metabolic gene expression, Figure 1)1. A few years later, 
the discovery of allosteric metabolite-protein interactions provided a mechanism for 
metabolite driven transcription (metabolic feedback on transcription, Figure 1)2. In our 
view, the crosstalk between metabolism and transcription results from two 
interdependent processes: information from transcriptional networks to metabolism is 
transmitted by metabolic gene expression, while metabolic information is conveyed via 
metabolic feedback on transcription.  
In the past decade systems biology has mostly been focused on genomes, 
transcriptomes and proteomes due to the availability of advanced and sensitive 
technologies. Recent improvements in metabolomics methods have now enabled 
metabolites to become the focus of many studies 3–6. The fundamental challenge for 
understanding how metabolites regulate transcriptional programs lies in identifying 
metabolites that are key signals for transcriptional regulators. This is illustrated by the 
fact that the master regulatory metabolite of catabolic genes in E. coli – alpha-
ketoglutarate - was identified only recently 7, despite the fact that the regulatory 
mechanism has been known since the early 1950s (carbon catabolite repression). Recent 
findings suggest that such metabolic feedback on transcription could govern global gene 
regulation and metabolism. For example, a recent study in yeast discovered that 
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seemingly pathway specific amino acid auxotrophies change up to 80% of transcripts 
and affect almost all metabolism 8. 
The potentially widespread presence of cross-talk raises the question of what cellular 
function emerges from this interdependence between transcription and metabolism. 
Here, we reviewed the past five years of literature that addressed these questions in 
microbial model organisms (mainly Escherichia coli and yeast). We will discuss the 
putative function of crosstalk in optimizing enzyme levels, and focus on system-level 
studies that either used experimental transcript and metabolite data or took more 




Figure 1: Schematic of the cellular processes that are involved in crosstalk between transcription and 
metabolism. Metabolic gene expression represents transcription and translation of a gene into a 
metabolic enzyme. Each enzyme catalyzes a certain reaction within the metabolic pathway (enzyme 
catalysis). Metabolic homeostasis implies that reaction rates A, B, and C are equal, that is, metabolite 
concentrations are constant and metabolic flux through the pathway is constant. Metabolites can interact 
with transcriptional regulatory proteins and modulate their activity (metabolic feedback on transcription). 
The example here shows an inhibition of a transcription factor (TF) by metabolite 4. The transcription 
rates of genes A, B, and C are then regulated by the activity of the transcription factor (transcription 
regulation). 
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1.1.1 - Metabolomics and transcriptomics studies indicate extensive 
crosstalk 
 
Intracellular metabolite concentrations are conserved between organisms. Absolute 
concentrations of primary metabolites in E. coli, yeast and mammalian cells are 
remarkably similar, with amino acids constituting the most abundant fraction of a cell’s 
metabolome 9. Despite such similarities, recent studies suggest that metabolite 
concentrations contain a high amount of information. Ralser and colleagues measured 
absolute amino acid concentrations in 4913 yeast strains, each bearing a different single 
gene deletion 10. For one third of these strains, the gene deletions caused significant 
changes in the levels of (individual) amino acids that were unexpectedly precise and 
specific. Each amino acid responded individually to gene perturbations, such that the 
signature of all 20 amino acids allowed functional annotation of genes as genes with 
similar amino acid signatures tended to be functionally related. The precision was so 
high that ribosomal genes, for instance, mapped to the ribosome structure. Similar to 
the case in yeast, a genome-wide study measuring 1,432 metabolites in E. coli showed 
that metabolite profiles were specific for gene deletions and enabled the inference of 
novel metabolism-related functions of many orphan genes 11.  Given that the 
metabolome holds such precise information on a cell’s status, to which extent is this 
information used by cells for gene regulation? The first evidence that metabolic 
information is extensively used in gene regulation networks comes from a 
comprehensive transcriptome analysis of yeast 12. In this study transcript profiles of 
1484 yeast strains with single gene deletions were measured using RNA sequencing. The 
gene regulation network inferred from these data indicated a striking number of 
metabolic feedback circuits, with many metabolic genes assigned as nodes in incoherent 
network motifs. The incoherent or “counter-intuitive” motifs were then interpreted as 
crosstalk between metabolism and transcription. A drawback of all three studies is the 
use of relatively extreme genetic perturbations. It would be important to address 
whether more subtle changes in gene expression yield similarly informative metabolite 
profiles. Combining CRISPR-based transcriptional perturbations of gene expression with 
high-throughput data has the potential to address such questions 13, but has not been 
applied to metabolite data so far.  
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1.1.2 - Information flow from transcription to metabolism 
 
Of the two aspects of cross-talk between transcription and metabolites, the expression 
of metabolic genes is the better characterized one as it follows the canonical flow of 
genetic information and has been studied extensively over the past decades. The 
comprehensive set of a cell’s metabolic reactions can be identified by combining whole 
genome sequencing, omics data and the abundant biochemical knowledge 14. The 
resulting set of metabolic reactions is then used to reconstruct genome-scale metabolic 
models (GSMs), where each reaction is associated to one or more proteins and the 
respective gene. These so-called gene-protein-reaction relationships are a holistic but 
static representation of metabolic gene expression. They list components, but do not 
allow the prediction of abundance or activity changes upon perturbations. The latest 
GSM of E. coli comprises 1366 genes and associates them to 2251 biochemical reactions 
and 1136 metabolites 15. The latest GSM of the yeast S. cerevisiae includes 904 genes, 
1412 reactions and 1228 metabolites 16. The static gene-protein-reaction relationships 
can be advanced with transcriptional regulation by assigning Boolean rules that define 
on/off states, as shown by Palsson and colleagues 17. In this framework, simple 
regulatory rules depending on environmental stimuli or internal metabolic flux 
distributions decide if a gene is expressed (on) or not (off), and therefore if a metabolic 
reaction can occur. Boolean rule–based methods have been extended to larger models 
18,1920  and were included in the first whole-cell model of a living organism 21. As these 
coarse binary rules can only define two states (on/off) they were later refined using 
probabilities to describe expression states 22. In this method, probabilistic weights were 
inferred from large datasets of gene expression, and then used to constrain metabolic 
fluxes based on the probability that a certain gene is transcribed.  
However, a caveat of the underlying metabolic models is that they are a purely 
stoichiometric representation of metabolism and therefore work with reaction rates 
(metabolic flux) instead of the potentially more informative metabolite concentrations.  
As a consequence, GSMs cannot evaluate how up- or down regulating an enzyme affects 
metabolite concentrations, and how these concentration changes propagate and alter 
metabolic fluxes. To address these questions, smaller dynamic metabolic models 
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including reaction-substrate relationships such as Michaelis-Menten kinetics, and 
allosteric regulation of enzymes have been developed 23. The currently most advanced 
kinetic model of E. coli metabolism comprises 457 reactions and 295 allosteric 
interactions 24, and was able to reproduce more than half of the measured metabolite 
concentrations. In conclusion, large genome-size metabolic models can - to some extent 
- evaluate the effect of gene expression on metabolic fluxes. However, evaluating the 
effect of gene expression on metabolite concentrations remains a fundamental 
challenge due to missing kinetic information.  
 
1.1.3 - Information flow from metabolism to transcription 
 
The transmission of metabolic feedback on transcription constitutes the reverse 
direction of information flow in cross-talk. Metabolic feedback is mediated by 
transcription regulation networks (TRNs), which describe the relationship between 
genes and their transcriptional regulators. Typical transcriptional regulators in 
prokaryotes are transcription factors (TFs), sigma factors and nucleoid proteins 25. In 
eukaryotic cells epigenetic DNA modifications, histone modifications and chromatin 
remodeling proteins constitute an additional layer of transcriptional regulation 26. TRNs 
have a hierarchical structure as transcriptional regulators can control other 
transcriptional regulators. The E. coli TRN was reconstructed using manually curated 
experimental data 27 and is the currently most complete TRN available. It covers 210 out 
of the ~300 predicted transcription factors and 3261 interactions between transcription 
factors and genes. In comparison, the S. cerevisiae TRN contains only 147 experimentally 
validated transcription factors out of a total of 250 predicted ones 28. Results from an E. 
coli study mapping physical DNA interactions for 116 transcription factors with SELEX 
indicate that transcription factors might have a wider DNA-binding spectrum than 
previously assumed 29. More than 80% of transcription factors were associated with 
more than 10 genes, with binding occurring in both noncoding and coding regions. 
However, even for the well-studied microbe E. coli the structure of the TRN is 
ambiguous, as topologies of TRNs depend on the method used to assign interactions of 
transcription factors and target genes. The total number of functional interactions can 
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be overestimated in pure binding-based methods, as false positive interactions arise 
from non-functional binding. Likewise, false negative interactions arise if regulation is 
condition-dependent, leading to an underestimation. Studies that assess TRNs with and 
without effectors, such as iron 30 or amino acids 31 enable mapping the condition 
dependent logic of TRNs.  
Once the structure of a TRN is defined the key challenge lies in identifying the most 
relevant input signals of transcriptional regulators. Previous findings in yeast show that 
many transcription factors are activated through post-transcriptional mechanisms 32. 
This observation was recently confirmed at the proteome-scale by absolute protein 
abundance data of E. coli in various environmental conditions 33. Indeed, transcriptional 
regulators were the most constant class of protein across all conditions. Post-
translational regulation mechanisms can be broadly divided into activity changes 
resulting from an upstream (externally stimulated) signaling cascade or from internal 
metabolic signals (e.g. reviewed in 34). While external signaling cascades and two 
component systems are well characterized, our knowledge on transcriptional regulators 
that sense internal metabolites is scarce. Even in the case of the arguably best-studied 
model microbe E. coli, direct interactions with metabolites have only been shown for 47 
out of the 210 transcription factors 35. This directly follows from the relative lack of 
scalable methods for identifying metabolite-protein interactions systematically. The 
gold standard for testing the effects of metabolites on transcriptional regulators are still 
low-throughput in vitro assays. Although new methods based on microarrays or affinity 
purification enable large-scale discovery of physical interactions between proteins and 
metabolites, they are limited to very stable interactions, which mostly occur with lipids 
and other hydrophobic metabolites 36,37. More recent methods to detect conformational 
changes by NMR 38 and proteomics 39 have so far focused on enzyme-protein 
interactions only. In summary, even though transcriptional circuits are well defined the 
lack of scalable methods for identifying metabolite-transcription factor interactions 
hinders the discovery of regulatory metabolites. An alternative to mapping physical 
interactions is the inference of cross-talk from multi-omics data, as discussed in the next 
section. 
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1.1.4 - Inference of cross-talk from multi-omics data 
 
Multi-omics datasets quantifying the abundance of transcripts, proteins and 
metabolites and the fluxes through metabolic networks across environments can 
theoretically be used to infer cross-talk. However, this requires systematic and often 
difficult integration of the different datatypes 40. Furthermore, experimental 
perturbations rapidly propagate within and between networks, which complicates 
inference of causal interactions. For this purpose, theoretical frameworks like Metabolic 
Control Analysis provide relationships between local and global responses in metabolic 
and transcriptional networks 41. In practice, however, these frameworks require very 
specific perturbations of single network components, such as up-and downregulation of 
single enzymes. This contrasts with the mostly very unspecific environmental 
perturbations, such as growth on different nutrients or stresses, used for generating the 
large majority of multi-omics datasets. However, in these cases other data-driven 
modeling approaches using either transcription rates or metabolic fluxes as starting 
points have been used, which will be discussed in the following two sections.  
Regulation of transcription rates  
To address whether metabolite levels are predictors of transcription rates, Kochanowski 
et al. measured metabolite concentrations and transcription rates of central metabolism 
promoters in 26 environmental conditions in E. coli 42. The study revealed that across 
environments about 30% of transcriptional changes were largely caused by activity 
changes of two transcription factors, Crp and Cra. Importantly, the authors were able to 
recover the known effector metabolites of both transcription factors, cyclic AMP and 
fructose-1-phosphate/fructose-1,6-phosphate, respectively, without prior knowledge. 
The remaining 70% of transcriptional changes in this study were caused by global 
growth-dependent regulation. Such large-scale transcriptional changes after 
environmental perturbations seem to be a general growth rate dependent effect in 
yeast and E. coli 43. So far only few other studies integrated metabolites with transcript 
data and focused mainly on coordinated responses in dynamic conditions 44,45.  
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Regulation of metabolic fluxes  
The majority of multi-omics studies use metabolic fluxes as starting points and search 
for correlation with other data types. The predominant conclusion from such studies is 
that transcripts are poor predictors of metabolic fluxes both in central carbon 
metabolism 46,4746 and on a genome-scale 4849. This is exemplified by flux and transcript 
changes between carbon and nitrogen limited yeast matching in just 53 out of 2194 flux-
transcript pairs 48. A systematic survey of computational methods arrived at the same 
conclusion 50, by showing that computational predictions of metabolic models were 
generally not improved by fitting measured transcript data. A recent multi-omics study 
in yeast by Rabinowitz and coworkers provided an explanation for this lack of correlation 
by showing that fluxes are mainly regulated at the post-transcriptional level 51. By 
systematically fitting enzymes, fluxes and metabolites to Michaelis-Menten type 
kinetics, the authors found that it was mostly substrates that controlled flux through 
their associated reaction. Substrate-dependent flux implies that most enzymes are not 
operating at their maximal possible velocity (vmax), but rather at sub-saturating 
conditions. This finding agrees with the tendency for overabundant enzymes in microbes 
as discussed in more detail in the next section and illustrated in Figure 2.  
In summary, recent studies show that is in principle possible to infer metabolite-
transcription factor interactions from multi-omics data 42. The scalability of this 
approach is an important aspect for enabling integration of large-scale transcriptional 
(e.g. Ref 52) and high-throughput metabolomics data 53. Moreover, the results from 
studies using metabolic flux as starting points for data integration support the prevailing 
opinion that fluxes are rarely controlled by abundance changes of enzymes 54. This raises 
the question why, if not for controlling metabolic flux, cells regulate enzyme levels. 




Figure 2: Robust versus efficient enzyme levels. (a) Enzymes in the metabolic pathway are overabundant and 
not operating at their full catalytic potential. The size of the enzyme indicates abundance and the blue fill 
activity. For example, enzyme B operates at half‐maximal velocity (v max). Perturbations can be 
compensated without regulating enzyme abundance by transcription (e.g., changing substrate 
concentrations). (b) Enzymes in the metabolic pathway are expressed at the minimum level that allows the 
same metabolic flux as in (a). All enzymes operate at their full catalytic potential (v max) and are saturated 
with substrates (the size of metabolites indicates the concentration). Decreasing a single enzyme level 
results in a metabolic bottleneck and in flux limitations. Transcriptional feedback regulation can compensate 
such perturbations, but slower than in (a). 
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1.1.5 - Crosstalk regulates enzyme levels  
 
Proteome data suggests enzyme overabundance 
The studies in the previous section investigated regulation of transcription rates and 
metabolic flux. A series of recent studies has taken enzyme levels into consideration. A 
comparative study of predicted metabolic flux based on an E. coli GSM and quantitative 
proteomics data by Palsson and colleagues revealed that measured enzyme levels are 
for the most part higher than predicted 55. Noor et al. demonstrated that for central 
metabolism such enzyme overabundance can be explained by enzyme saturation and 
thermodynamic effects 56. Other approaches that compare enzyme abundance and 
enzyme kinetics were recently reviewed by Davidi and Milo 57.   
Several hypotheses have been proposed for explaining the existence of pervasive 
enzyme overabundance 54: On the one hand enzyme overabundance could simply be a 
result of imperfect regulatory mechanisms. However, there could also be an important 
functional role for this phenomenon, for example by providing a buffering mechanism 
against internal and external fluctuations or by enabling flux control via fast-acting 
allosteric interactions. In the latter case the unused enzyme fraction can be activated 
instantaneously, whereas expressing new enzymes would take time and result in a 
potential fitness cost. Such an fast acting allosteric mechanism can, for example, be 
observed in E. coli glycolysis: it allows unused glycolysis enzyme to be allosterically 
activated within 5 seconds of a shift from gluconeogenetic to glycolytic nutrients 58. 
Having established that cellular enzyme levels tend to be higher than absolutely 
required to explain flux we will in the following sections focus on the cellular objectives 
that define enzyme levels and on the role of cross-talk in regulating enzyme levels.  
Which cellular objectives define enzymes levels? 
From an evolutionary perspective we would expect that cells tune enzyme levels to 
optimize fitness parameters and overall physiology. However, to which degree enzyme 
levels have been optimized through the course of evolution is a fundamental and 
longstanding question 59. The most direct way to test optimality of enzyme levels for 
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fitness is to vary the levels of single enzymes in vivo and measure growth or other fitness 
parameters. In yeast, such a titration of the levels of enzymes and other proteins has 
recently been achieved using barcoded promoters with a 500-fold expression range 60. 
The study demonstrated that changing single enzyme levels below and above wild-type 
levels rarely improves growth, implying that enzyme levels of the wild type strain are 
already optimized for maximum growth in glucose. However, the observation that wild-
type expression was only optimal for growth on glucose, but not on galactose, indicates 
that it is difficult for cells to optimize enzymes levels in all possible conditions, as already 
suggested before 54. Similarly, Milo et al. show that in various conditions around 30% of 
the total enzyme pool in E. coli carries no metabolic flux, suggesting again imperfect 
regulation 57. Furthermore, optimality criteria of enzyme levels may involve multiple, 
even conflicting objectives that are not reflected by growth rates or metabolic flux 
alone.  This is illustrated by a study in B. subtilis , which used CRISPR-based repression 
of single essential genes, resulting on average in a three-fold down-regulation of protein 
levels 61 . While 80% of all strains with single gene knockdowns showed growth similar 
to wild-type, 95% had problems to resume growth after stationary phase (reflected by 
long lag-phases). This implies that expression of most genes may be optimized for 
dynamic conditions and to a lesser extent to achieve maximal growth rates. In a different 
approach, Alper and colleagues used a CRISPR-based system to gradually express 
enzymes in metabolically engineered yeast and test the sensitivity of metabolic flux 62. 
In a third approach Panke et al used ribosomal binding site libraries to unravel design 
principles of optimal enzyme levels in a synthetic metabolic pathway 63. In conclusion, 
novel genome engineering methods enable exploring the relationship between cellular 
fitness and enzyme levels at large-scale. These studies show that enzyme levels seem to 
be optimal for different fitness aspects in different species: for maximum growth on 
glucose in yeast 57 and for growth resumption after stationary phase in B. subtilis 61. 
Next, we searched for studies demonstrating that cross-talk between metabolism and 
transcription controls enzyme levels dynamically. 
Cross-talk enables self-optimization of enzymes levels 
As discussed in the last section, there seems to be optimization of enzyme levels to some 
extent. But how do cells achieve these optimal levels? A series of studies provide 
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evidence that cross-talk might be an important mechanism to “self-optimize” enzyme 
levels, meaning that optimal enzyme levels are an emergent property of cross-talk 
between transcription and metabolism. To test this hypothesis, cross-talk between 
metabolism and transcription can be disrupted by externally added regulatory 
metabolites. Alon and colleagues recently used such an approach to examine cross-talk 
between central carbon metabolism and transcription of catabolic genes 64. By supplying 
E. coli cells externally with the metabolite cyclic AMP (cAMP) the authors were able to 
gradually change transcription of catabolic genes. Their results demonstrate that 
expressing catabolic genes at wild-type levels is optimal for growth on some nutrients, 
but sub-optimal on others. Therefore, in some environments, crosstalk via carbon 
catabolite repression enables E coli to optimize levels of catabolic enzymes. The more 
detailed mechanism underlying cAMP regulation of carbon catabolite repression is 
described in Ref. 7. 
Self-optimization not only seems to occur for catabolic enzyme levels but also for 
ribosomes 61,65. Bruggeman and colleagues showed that optimal ribosome levels result 
from cross-talk between amino acids and transcription of ribosomal genes. To this end, 
they developed a small-scale model of amino acid and protein synthesis, which achieved 
self-optimization of ribosome levels 66. Mechanistically the model represented the well-
studied transcriptional program centered around the secondary messenger (p)ppGpp.  
A similar function of (p)ppGpp mediated cross-talk between amino acids and 
transcription of ribosomal genes was suggested by Scott et al. 67. Cross-talk functions as 
a “supply driven activation” of ribosomal gene transcription, which is a simple yet robust 
mechanism to optimize ribosome levels. However, “supply driven activation” alone 
could be sub-optimal in dynamic conditions. A small-scale model suggests that feedback 
inhibition by transcriptional repressors plays an important role during nutritional up- 
and downshifts 68. In this scenario strong transcriptional feedback would emulate an 
“on-off” control strategy, which enables additional optimization of the levels of amino 
acid biosynthesis enzymes in dynamic conditions. While the examples above show that 
cells optimize the larger fractions of their proteome by cross-talk (the sum of catabolic 
enzymes and the sum of ribosomal proteins), it is currently not clear if this happens for 
smaller fractions or individual enzymes as well. Some support for the presence of self-
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optimization in smaller metabolic modules (between 150 and 250 enzymes per fraction) 
comes from clustering of quantitative proteome data 69. Finally, several studies provide 
evidence that E. coli optimizes a single bottle-neck enzyme in the methionine 
biosynthesis pathway 35, and that cross-talk in glycolysis may be geared towards optimal 
glycolysis flux 70. 
 
1.1.6 – Discussion 
 
Several lines of evidence have shown that microbial cells express more enzymes than 
they absolutely need for maintaining physiological flux 51,54,55. Given the potential 
burden resulting from overexpressing enzymes it seems likely that this overabundance 
has a functional role in microbial physiology. The prevailing opinion is that higher than 
needed enzyme levels prevent bottlenecks in metabolic pathways: by default, each 
enzyme operates at sub-maximal velocity (vmax), which allows metabolites to rapidly 
change the current reaction velocity (e.g. by substrate-saturation or allosteric feedback). 
However, an alternative hypothesis is that cells actively accumulate enzymes in nutrient 
rich conditions, to protect against potential stresses in future conditions.  
In the previous paragraphs we have summarized studies that support a role of crosstalk 
between transcription and metabolism in adjusting enzyme levels. There is evidence for 
both small (individual enzymes) and large-scale (catabolite repression) optimization. But 
there are more than 1000 distinct enzymes in an E. coli cell and it is unknown if of each 
of them is regulated individually. If the level of a single enzyme accidently falls below a 
flux limiting threshold this can be counteracted by two distinct mechanisms: global 
upregulation of all enzymes, which is probably more costly, and upregulation of just the 
critical flux-limiting enzyme. The current literature provides evidence for both scenarios. 
On one hand, recent findings based on metabolomics data indicate that metabolites 
carry very specific information about cellular processes 10,11. Such localized and specific 
changes in metabolite levels could enable highly precise crosstalk to control levels of 
each enzyme individually. On the other hand inference from multi-omics data has 
revealed only sparse crosstalk between metabolism and transcription 42,47. In fact, global 
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growth-rate dependent transcriptional regulation seems a major driver of gene 
expression 43. It will be important to clarify if these global effects result from the very 
unspecific environmental perturbations applied in the studies. Global regulation could 
be the main driver upon broad-ranging external perturbations, whereas more localized 
internal perturbations invoke more specific metabolite-driven gene regulation. 
We have focused on studies in microbial model organism, which leveraged the system-
level understanding about metabolism and transcriptional regulation in these cells. A 
direct benefit of such studies is that methods can be transferred and applied in medical 
and biotechnological research. For example, a novel proteomics-based method to 
detect metabolite-protein interactions in yeast was recently transferred to T-cells 71. The 
method allowed identification of transcription factors that interact with the amino acid 
L-arginine and thereby promote anti-tumor activity. It remains to be seen if regulatory 
principles in simple microbial model systems apply to higher, multicellular organisms. 
Given the strong conservation of core cellular processes across evolutionary scales it 
seems likely that at least the more general principles are conserved. We have discussed 
the central role of alpha-ketoglutarate as a master regulatory metabolite of catabolic 
genes in bacteria. The same signal plays an important role in other organisms: Alpha-
ketoglutarate concentrations control mTORC1 activity in mammalian cells 72, and 
increased alpha-ketoglutarate levels are associated with an extended life span in 
Caenorhabditis elegans 73. However, currently it still unclear if the same signal has the 
same function in these cells, or if its function has been altered in higher organism.  
Finally, biotechnological applications that utilize microbial model organism to produce 
chemicals will directly benefit from insights about regulatory cross-talk in these cells. 
Especially metabolic engineering applications require high enzyme levels to enforce high 
fluxes in synthetic metabolic pathways. However, strong overexpression of 
heterologous enzymes results in burden and instability in production strains 74. 
Understanding principles that optimize enzyme levels in natural pathways could serve 
as blue-print to control enzyme levels in synthetic pathways dynamically. The great 
challenge lies in designing synthetic cross-talk, but linking transcription factors to new 
metabolites is already possible (the lac repressor in this case) 75. 
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Finally, the answer to the question how much enzyme is enough certainly depends on 
the organism, the context and the metabolic function of the enzyme. Even in simple and 
well-studied model organisms we are just starting to be able to address this question 
systematically. In our view, the control of enzyme levels is intimately linked with 
crosstalk between transcription and metabolism, and therefore central to 
understanding the role of this cross-talk. It is likely that cells have acquired a certain 
“knowledge” of how much enzyme is enough in various environments. The question is 
to what extent single metabolite concentrations encode this knowledge. 
 
1.2 - Mass spectrometry-based methods for systems biology 
studies 
 
Systems biology is a holistic approach to biological research as it strives to understand 
biological complexity as a whole, rather than as the sum of its single entities. The key 
driving force of this approach has been the development of various omics methods to 
measure molecules in a high throughput manner and their eventual combination in 
multi-omics studies 76. In the context of metabolism, the two main molecular entities of 
interest are metabolites and enzymes. The comprehensive measurement of metabolites 
is defined as metabolomics. In order to study enzyme abundances, a direct measure of 
proteins through proteomics has been shown to be more suitable than indirect 
methods, as in example RNAseq. Comparative studies have shown that in various 
prokaryotic and eukaryotic organisms transcript levels do not correlate with levels of the 
respective protein 77,78. This is due to various reasons, such as different translational 
rates, post-translational modifications, different degradation rates, etc. The direct 
measurement of proteins and metabolites in a high throughput manner can be achieved 
through mass-spectrometry (MS), an analytical technique which relies on measuring the 
mass-to-charge ratio (m/z) of electrically charged molecules. 
MS-based proteomics enables to measure the composition of protein samples 79, and a 
typical method to measure such complex mixtures from biological samples is shotgun 
proteomics 80. Proteomic workflows (Figure 3) start with the extraction of proteins from 
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a biological sample and their digestion into peptides, using a protease with a defined 
proteolytic specificity. The digested samples can then be purified and run through a 
liquid chromatography (LC) column which separates peptides based on their interaction 
with the column. The eluting peptides are then ionized and by entering the mass-
spectrometer they are separated and detected based on their m/z. In tandem MS 
(MS/MS), the charged peptides exiting the first mass-spectrometer are further 
fragmented to undergo a second MS measurement, allowing the identifications of ions 
that had similar m/z ratios in the first mass spectrometer. The detected mass spectra 
can be used to identify peptide structures. The identified peptides, are then compared 
to a peptide list obtained by an in silico digestion of the theoretical proteome, inferred 
from the relative genome of the biological sample. Based on the mapped peptides, the 
relative protein abundance can be estimated 80. This methodology can be applied to 
obtain relative quantifications of protein levels between different samples. In order to 
measure protein concentrations in absolute terms, samples can be spiked with 
isotopically labeled standards before being measured. Such methods have been used to 
estimate absolute concentrations of thousands of proteins, effectively quantifying the 
proteome compositions of organisms 81. 
Due to the small mass of metabolites, MS-based metabolomics methods do not require 
fractioning of the collected samples, which is a lengthy procedure in MS-based 
proteomics. MS-based metabolomics methods can be performed in an untargeted 
manner, measuring known and unknown chemical species of a sample, or in a targeted 
manner, in which only a subset of well annotated metabolites is measured. Untargeted 
metabolomics is characterized by speed and throughput of measurements, rendering 
these methods powerful tools for large screenings of biological samples 82. On the other 
hand, targeted metabolomics focuses on analyzing a defined set of biochemically 
characterized molecules, enabling quantitative measurements of metabolites and 
estimation of their concentrations. Advancements in manufacturing of shorter LC 
columns with decreased particle sizes have considerably increased the speed at which 
metabolomics samples can be eluted into the mass-spectrometer. Novel targeted LC-
MS/MS methods can precisely measure hundreds of metabolites with run-times 
reduced from 30-60 minutes to few minutes 83,84. In a typical metabolomics LC-MS/MS 
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workflow (Figure 3) to measure intracellular metabolites, samples are first filtered to 
dispose of their cultivation media and then lysed using a variety of solvents. The 
utilization of cold acidic acetonitrile solvents for sample preparation can preserve 
unstable compounds as nucleotide triphosphates 85. Prepared samples are then eluted 
with LC to separate metabolites and subsequently measured by MS/MS in a similar 
manner as for proteomics. Measured m/z spectra can be then used to quantify in 
relative terms metabolite abundances. Higher precision of measurements can be 
obtained by spiking samples with isotopically labeled standards, improving peak 
identification throughout long series of measurements and enabling absolute 
quantification of metabolite concentrations 86,87.  
In this work, we employed shotgun proteomics and/or targeted metabolomics to 
measure thousands of proteins and hundreds of metabolites (Chapter 3-4). Moreover, 
we studied the response of the E. coli metabolome under different environmental 
conditions (Chapter 5). Analyzing omics data from a range of different strains/conditions 
allowed us to infer basic principles of microbial metabolism. 
 
1 - Introduction 
 18   
 
Figure 3: Scheme summarizing an MS-based multi-omics workflow. Shotgun proteomics is highlighted in 




1.3 - CRISPR interference, a tool for the control of gene 
expression 
 
The discovery of clustered regularly interspaced short palindromic repeats (CRISPR) and 
CRISPR associated proteins (Cas) has been a considerable breakthrough, with wide 
consequences for molecular biology and genetic engineering 88. CRISPR/Cas systems are 
originally found in archaea and bacteria 89. Most of them function as an immune 
adaptive defense mechanism against exogenous nucleic acids, as for example against 
phage infections 90. CRISPR/Cas immunity relies on the formation of a complex between 
Cas proteins and short RNAs expressed from CRISPR arrays (crRNAs). crRNAs contain a 
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short sequence (spacer) which allows the complex to recognize and bind by base pairing 
a complementary target DNA or RNA (protospacer). In order to be recognized and bound 
by the complex, protospacer sequences need to be followed by a short protospacer 
adjacent motive (PAM), which serves cells to distinguish between self and non-self DNA. 
Upon recognition and binding of a correct protospacer, the endonuclease domains of 
Cas proteins can cleave the bound target. CRISPR/Cas effector complexes are 
characterized by a high binding specificity thanks to base-pairing, which has led to the 
repurposing of these systems for a number of applications. 
In this context, the CRISPR/Cas effector complex from Streptococcus pyogenes is widely 
utilized, due to its stability in different organisms and its dependence on few elements: 
one single Cas protein (SpCas9) and two small RNAs. The crRNA contains the spacer 
sequence that guides the complex, while the trans-activating crispr RNA (tracrRNA) plays 
a role in the maturation of the crRNA 91. The CRISPR/Cas9 system cleaving activity has 
been exploited most notably for genome engineering of bacteria and eukaryotes 92. On 
the other hand, a successful application of the specific RNA-guided targeting has been 
the repurposing of SpCas9 to repress gene expression, technique known as CRISPR 
interference (CRISPRi) 93,94. CRISPRi relies on SpCas9 proteins with mutated nuclease 
domains (dead Cas9 or dCas9) and a synthetic small guide RNA (sgRNA), comprising a 
spacer sequence of 20 nucleotides (Figure 4A). Upon their expression and formation, 
the dCas9/sgRNA complexes can recognize and strongly bind a target DNA sequence, 
without cleaving the target. Directing the complexes to genes of interest, using 
specifically designed sgRNAs, can prevent their transcription causing gene expression 
knockdowns. The strongest interference effects were demonstrated for spacer 
sequences designed to bind protospacers located in the non-coding strand of a gene at 
their 5’ UTR or the coding region of a gene, in proximity to the translation initiation 
sequence (Figure 4B)95.  
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Figure 4: scheme of CRISPRi components and mechanism. (A) Components of a CRISPRi system. The 
scheme illustrates a dCas9/sgRNA complex. The spacer sequence is indicated in red. In orange, the 
protospacer sequence. In purple, the PAM. (B) Mechanism of a CRISPRi system. The dCas9/sgRNA complex 
scans the DNA to find a correct PAM and protospacer, and upon recognition binds the DNA. The scheme 
illustrates the strongest mode of interference, in which the complex is directed to stop RNA polymerases 
recruited to transcribe a gene into mRNA, and the spacer sequence binds the non-coding strand. 
Interrupting mRNA elongation effectively knocks down gene expression of the targeted gene.  
 
CRISPRi can be easily reprogrammed by changing the 20-nucleotide sequence of the 
sgRNA. This enables the creation of large strain libraries which have been used 
extensively for genome-scale functional screenings, both in prokaryotes 96–98 and 
eukaryotes 96,99,100. Moreover, CRISPRi has also been utilized in metabolic engineering 
studies to tune levels of enzymes and redirect flux towards production of particular 
compounds 101,102. In this work, we exploited CRISPRi to study robustness of microbial 
metabolism. We designed and prepared CRISPRi strains in which we could artificially 
enforce lower enzyme levels. We then studied the response of cells, by measuring 
growth, proteins and/or metabolites. The initial design of the strains and testing of the 
CRISPRi experimental setup is described in Chapter 2. In Chapter  we employed CRISPRi 
to perturb all metabolic genes in E. coli and to produce the biggest multi-omics dataset 
of CRISPRi strains to date. 
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2 – Characterization of CRISPRi-knockdowns of 
metabolic genes 
 
2.1 - Results 
 
2.1.1 - Comparison of different CRISPRi systems 
 
A key factor for perturbing and studying metabolism is the utilization of expression 
systems orthogonal to the metabolic network of an organism. For this reason, we tested 
expression systems inducible by anhydrotetracycline (aTc) 103, a tetracycline which does 
not bloc bacterial protein synthesis. We compared two CRISPRi systems, inducible by 
aTc: a plasmid based CRISPRi system (pCRISPRi)95 and a system relying on a dCas9 gene 
integrated in the genome of E. coli, with an optimized tetR promoter (YYdCas9)104(Figure 
5A). We transformed both strain with a plasmid expressing an empty control gRNA 
(control strain) or a plasmid containing a sgRNA with a spacer sequence targeting a gene 
(ilvC strain) encoding for the ketol-acid reductoisomerase. Upon growth on minimal 
medium with glucose, ilvC is known to be an essential gene 105. We cultivated the four 
strains in minimal medium with glucose, supplementing or not 200nM of the inducer 
aTc. For the pCRISPRi system, we could observe a slight reduction in growth for the 
induced control strain, compared to the uninduced culture (Figure 5B). This might be 
caused by a growth burden, due to leaky expression of dCas9. This leaky expression was 
further confirmed by the fact that the strain containing a functional sgRNA, experienced 
an even greater growth reduction in absence of the inducer. When adding the inducer 
of dCas9, growth of the ilvC strain was severily impacted. In contrast, the YYdCas9 strains 
performed as expected (Figure 5C). Addition or not of the inducer did not cause 
differences in growth for the control strain. Moreover, the ilvC strain in absence of 
inducer grew exactly as the control strain, indicating low or negligible levels of dCas9 
leaky expression. Finally, when cultivating the ilvC strain in presence of aTc, expression 
of dCas9 caused an expected growth reduction due to lower levels of the targeted ilvC 
gene and the relative essential enzyme. A YYdCas9 strain with gRNA targeting the 
essential cell division gene ftsZ confirmed the inducibility of the interference system 
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(Figure S1). Overall, these results suggest that the YYdCas9 system is more suitable for 
inducible CRISPRi experiments.  
 
Figure 5: Comparison of different CRISPRi systems. (A) Scheme representing the two compared CRISPRi 
expression systems. Plasmids pdCas9-bacteria and pgRNA-bacteria were transformed in E. coli 
BW25993. pgRNA-bacteria plasmids were transformed into YYdCas9. Upon addition of aTc in cultures of 
strains with a functional sgRNA, we expected to observe a gene expression knockdown, consequent 
lower enzyme levels and possibly a growth defect. (B) Results of the growth screening for the pCRISPRi 
system. OD600 in ln scale and growth rate over time, lines represent average of replicates (n=3), grey 
shadowed areas represent standard deviation. aTc was added at T=0. (C) Results of the growth 
screening for the pCRISPRi system. OD600 in ln scale and growth rate over time, lines represent average 
of replicates (n=3), grey shadowed areas represent standard deviation. aTc was added at T=0. 
 
 
2.1.2 - Screening of an arrayed library of CRISPRi strains 
 
We then set to investigate a larger number of YYdCas9 strains. We selected 110 genes 
in primary metabolism of E. coli and designed pgRNA plasmids with sgRNAs targeting 
the strongest theoretical PAM site on the open reading frame of the gene 94. The targets 
included genes encoding for enzymes in central carbon metabolism (25 enzymes), 
2 – Characterization of CRISPRi-knockdowns of metabolic genes 
 
23 
biosynthesis of amino acids (34 enzymes), nucleotides (16 enzymes) and cofactors (31 
enzymes). Four enzymes were involved in other pathways (fatty acid biosynthesis, 
phospholipid biosynthesis, lipopolysaccharide biosynthesis, Autoinducer-2 synthesis). 
85 out of 110 chosen genes are essential for growth on glucose minimal medium (EcoCyc 
Database) 106. When possible, we avoided targets that are in operons: 73 of the 110 
target-enzymes are encoded by genes that are expressed singularly. The pgRNA 
plasmids were synthesised or cloned and transformed into YYdCas9 to obtain an arrayed 
library (Table S1). We measured growth 111 CRISPRi strains (110 + control strain) on 
glucose minimal medium, with and without induction of dCas9. All 110 CRISPRi strains 
grew similar to the control strain, when dCas9 was not induced (Figure 6A). To induce 
enzyme knockdowns, we added aTc at the start of cultivation and the induced cultures 
displayed a wide range of growth characteristics (Figure 6A). Knockdowns of 64 out the 
110 enzymes caused a growth defect during the first 8 hours of exponential growth. 
However, the growth phenotypes appeared with a time delay of at least 3 hours after 
induction of the knockdown. Even strains with a very strong growth phenotypes grew 
initially like the control. We assumed that enzyme-levels would decrease exponentially 
after induction of dCas9 expression. Thus, growth phenotypes would appear early if the 
target-enzyme is expressed near a critical (flux limiting) level in the wild-type. In 
contrast, late or no growth phenotypes would indicate enzymes that are overabundant 
in the wild-type. To test this hypothesis, we calculated a response time (tau) as the time 
point when growth phenotypes appeared in the induced cultures (Figure 6B), and we 
calculated tau values for all strains (Figure 6C). We observed the shortest response time 
for knockdowns of MetE in methionine biosynthesis (3 h) and PyrE in nucleotide 
biosynthesis (3.3 h). This is consistent with our expectation that critical enzymes have 
the shortest response times, because MetE is a large and slow protein that limits overall 
protein synthesis 107; and PyrE is sub-optimally expressed in K12-derived E. coli 108. In 
central carbon metabolism, we observed the strongest response for knockdowns of the 
PTS system (PtsH) and the enolase (Eno): PTS is essential for carbon transport on glucose 
as sole carbon source 109, while Eno is a key limiting step for glycolysis in cells grown on 
glucose 110. Finally, Idi is a known rate-limiting step for the synthesis of isoprenoids 
111,112. The median response time of all 110 target enzymes was 5.58 hours. Amino acid 
biosynthesis enzymes had the shortest response time (4.5 h). The higher sensitivity of 
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amino acid biosynthesis enzymes is expected, because their expression is tightly 
regulated by transcription factors and transcriptional attenuation 113. Targets in cofactor 
metabolism and nucleotide biosynthesis had longer response times (6 h). Cofactor 
metabolism was the category with the highest fraction of target-enzymes that caused 
no growth phenotype at all (16 out of 31). The high robustness of cofactor metabolism 
matches previous reports showing that cofactors are stable and that their concentration 
is higher compared to the actual requirements for growth 114. Overall, these results show 
that for a larger number of strains the chosen CRISPRi system is tight and inducible. 
Moreover, the delay between induction and appearance of growth phenotypes in 64 
strains, as well as the absence of growth phenotypes in the other 46 strain, shows that 
E. coli is robust against knockdowns of enzymes. The response time to enzyme 
knockdowns might reflect whether enzymes are expressed near a critical level or if they 
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Figure 6: Growth screening of an arrayed CRISPRi library of 110 strains. (A) Growth curves of 110 CRISPRi 
strains carrying different sgRNA targeting expression of enzymes in the E. coli primary metabolism. In 
black are shown growth curves without addition of aTc, in orange with addition of aTc at Time = 0. Growth 
curves represent means of n=3 cultures. (B) Growth curves of the pfkA CRISPRi strain. Colors of curves as 
in Figure 1C. Growth curves represent means of n=3 cultures. Response time (t) was calculated as the time 
in which the induced/un-induced curves would diverge by more than 20% at OD > 0.12. (C) Response time 
(t) for the 110 strains of the CRISPRi library, divided by metabolic subsystems. t was calculated as 
described in Figure 2B using data from Figure 1A. Strains that experienced a t in the first 8 hours of 
exponential growth are shown in the plot, strains that did not display a t in the first 8 hours of exponential 
growth are counted in the panel at the right. 
 
2.1.3 - Proteomics-based characterization of CRISPRi strains 
 
In order to setup a sampling protocol for multi-omics data gathering, we first wondered 
whether the initial number of cells could affect the time in which growth phenotypes 
would arise. We inoculated different YYdCas9 strains (targeting argA, argE, purM) at 
different starting optical densities, and measured growth (Table S2). We could observe 
that regardless of the initial concentration of cells in the culture, the response time 
would be comparable for all the three strains. Therefore, a similar CRISPRi response 
happens in strains that are inoculated at lower or higher initial concentrations. This 
result implies that the initial inoculum can be adjusted to obtain enough biomass in 
exponential growth for metabolomics/proteomics sampling. We then moved to verify 
how proteins are affected by the chosen CRISPR interference setup, before and after a 
growth reduction takes place. Sampling cells earlier than the observed phenotype might 
prevent to detect significant changes in gene expression triggered by the metabolite 
perturbation. On the other hand, cells sampled after growth reduction might undergo 
global stress responses. We chose three strains from the library that displayed a growth 
reduction phenotype when subject to CRISPRi. The chosen strains included guides 
targeting essential genes in amino-acid biosynthesis (metE), glycolisis (pfkA) and 
isoprene biosynthesis (ispH). MetE and PfKA are the most active isoforms for their 
reaction (respectively 2.1.1.14 and 2.7.1.11), and are encoded as single ORFs. IspH is the 
only enzyme predicted to carry a key reaction in isoprene synthesis (EC 1.17.7.4) and is 
encoded as the last gene of its operon. After a 16h pre-culture in m9 minimal medium, 
we inoculated the strains at a starting OD of 0.05 in 35mL of medium in flasks, in 
presence or absence of aTc, in duplicates. For each flask, we took samples for 
proteomics at two timepoints (5mL of culture at OD=0.2, 2mL of culture at OD=0.5) and 
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measured OD600. Unlike the metE and pfkA strains, the ispH strain did not experience 
a reduction in growth when inducing dCas9 expression and grew as the control strain 
(Figure 7A). 
Figure 7B displays the protein abundances of the interfered genes and of dCas9 for every 
strain, relative to the uninduced control. For all strains, when applying aTc, the dCas9 
abundance increased by c.ca 5 times. Interestingly, dCas9 was detected also in cultures 
without aTc induction, meaning that the optimized tetR expression cassette of YYdCas9 
permits a low basal level of expression. However, no strong reduction in the target 
proteins was detected in the strains cultivated without aTc. The low concentration of 
dCas9 might be insufficient to cause significant interference to the genes targeted by 
the dCas9-sgRNA complex. For all the tested strains cultivated with aTc expression of 
the targeted gene was reduced by more than 2-fold. We moved to verify how the rest 
of the proteome reacted to the CRISPRi induced bottlenecks.  
From the 1760 detected proteins, we trimmed proteins which had either a lower 
peptide count than 2 or variability between replicates higher than 20%. Calculating fold 
change of the data over the protein dataset available for the control strain, led to high 
variability of differentially expressed genes (DEGs) (Figure S2). In example, for the metE 
strain many flagellar related genes resulted to be up-regulated for both conditions and 
both time-points compared to the Cntrl strain. Probably the metE strain underwent a 
common transposon related mutation 115. Moreover, stress related proteins (as rpoS) 
appeared to be upregulated for strains sampled at T2. Therefore, we calculated the fold-
change for every strain to the relative uninduced strain at T1 reducing the number of 
DEGs. Then we calculated fold-change for every dataset to the relative un-induced strain 
at the same time point, reducing the DEGs even further (Figure S2). Therefore, it appears 
that comparing data from induced cultivation to the not induced cultivation for the same 
strain contributes to reduce significantly noise in the data. Figure 7C depicts proteome 
changes for the strains at T2, normalized to the relative un-induced control. For the 
Control strain only dCas9 displays a significant upregulation, highlighting that expression 
of dCas9 does not cause significant perturbations at the proteome level. For the metE 
strain, several genes related to methionine synthesis, salvage and transport appear to 
be upregulated. Many of these genes are normally repressed by the TF metJ in its active 
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form, when binding S-adenosylmethionine (SAM). A reduction in methionine 
biosynthesis could lead to a reduction in SAM, reducing repression from metJ. For the 
pfkA strain, glycolytic genes did not appear to be upregulated significantly. Genes 
related to the glyoxylate cycle (aceA, aceB), maltose uptake and utilization (malM, malE, 
malF) and glutamate degradation (gadB) appeared to be up-regulated. A malate 
dehydrogenase (mqo) was strongly downregulated. For the ispH strain only the fkpB 
gene was downregulated, possibly because of its position in the ispH operon. However, 
a proteome-wide response upon 2 fold lower levels of IspH could not be observed. 
 
2 – Characterization of CRISPRi-knockdowns of metabolic genes 
 28   
 
Figure 7: Characterization of 4 CRISPRi strains. (A) Growth curves for the 4 strains. Black lines represent 
growth of strains (n=2) without induction of dCas9 expression, orange lines represent strains growing in 
presence of aTc. Vertical dotted lines represent proteomics sampling timepoints (T1, T2). The control 
strain was sampled only at a single timepoint. (B) Bar plots representing abundance of selected proteins 
(n = 2), normalized to the proteome data of the uninduced control strain. Error bars represent the 
propagated error. (C) Volcano plots for proteomes of the CRISPRi strains, normalized to the proteome of 
the relative un induced strain at the same timepoint (T2). Red dotted lines represent cutoffs for fold 
change (FC>2, vertical lines) and significance (p-value>0.05, horizontal lines). 
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2.2 - Discussion 
 
Here, we set to characterize and optimize a setup to precisely perturb metabolic genes 
using CRISPRi. We show that a strain with a genomically integrated dCas9 cassette can 
obtain an inducible activation of CRISPRi, without affecting cell physiology due to burden 
or dCas9 toxicity, as it has been shown previously when overexpressing dCas9 116. 
Screening a large library of CRISPRi strains targeting metabolic genes confirmed 
inducibility of the strain. We could observe that interference of different genes enforces 
a wide range of response times. Known rate limiting enzymes as MetE and PyrE had the 
shortest response times, confirming the hypothesis that the degree of the response time 
might reflect whether enzymes are expressed near a critical level or if they are made in 
excess. Moreover, even for such rate-limiting enzymes the response occurred 3 hours 
after inducing CRISPRi, and for many other strains the response time was longer or 
absent. We then set a sampling experiment to verify the response of cells to CRISPRi at 
the molecular level. dCas9 levels increased in all induced cultures, while the targets of 
interference were correctly reduced in their concentrations in the relative conditions. 
We could observe that comparing data from induced and uninduced cultures sampled 
at the same time allows to avoid noise and identify specific responses caused by enzyme 
downregulation. When normalizing the data in such way, we could observe specific 
responses for 2 of the analyzed strains. In the case of the metE strain, we could observe 
a specific upregulation of related genes in methionine biosynthesis. When perturbing 
expression of pfkA we observed an upregulation of transporters and TCA cycle related 
genes. In both cases, the perturbation seemed to become stronger with time. In the case 
of the ispH strain, we could not observe a significant response in gene expression or in 
the metabolome. Interestingly, ispH is known to be an essential gene for E. coli in the 
tested cultivation conditions, as metE and pfkA. It could be speculated that an unknown 
isoenzyme or an enzyme with moonlighting activity 117 can compensate measured lower 
amounts of IspH. Alternatively, it could be possible that IspH does not function at full 
capacity and that therefore the enzyme was not diluted to a critical concentration. 
Overall, we show here that integrated dCas9 cassette integrated in the genome of E. coli 
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allows for precise and burdenless interference of gene expression, which can be 
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3 - The metabolome buffers CRISPRi-knockdowns of 
enzymes in E. coli metabolism  
 
3.1 - Results 
 
3.1.1 - An inducible CRISPRi system identifies rate-limiting enzymes 
 
For dynamic knockdowns of enzymes, we used a CRISPRi system that consisted of an 
aTc-inducible dCas9 on the chromosome 104, and a constitutively expressed single guide 
RNA (sgRNA) on a plasmid 94 (Figure 8A). To evaluate dynamics of gene interference with 
this CRISPRi system, we targeted a YPet reporter protein inserted in the E. coli genome 
104. These experiments showed an exponential decrease of the YPet content per cell, 
indicating a constant dilution of the YPet protein by growth (Figure 8B). The 1-hour delay 
between inducer addition and decrease of YPet is probably occurring due to the time of 
dCas9 expression and its target search 118. Moreover, YPet expression was only 
repressed in the presence of the dCas9 inducer aTc, showing tight control of the CRISPRi 
system (Figure 8B). Thus, CRISPRi allowed us to dynamically decrease the abundance of 
proteins starting from unrepressed (wild-type) levels. 
To further test the dynamics of the CRISPRi system, we targeted genes encoding 
enzymes in pyrimidine nucleotide biosynthesis. All pyrimidine enzymes are essential for 
growth of E. coli on glucose minimal medium. Therefore, knockdowns of pyrimidine 
genes should cause a growth defect when enzyme-levels reach a critical threshold. At 
this threshold the target-enzyme limits biosynthesis of UMP, and eventually affects 
growth (Figure 8C). Expression of dCas9 was either induced by supplementing aTc at the 
start of the cultivation (induced cultures), or cells were grown without inducer (un-
induced cultures). A control strain without target grew similar in induced and un-
induced cultures, which means that dCas9 expression alone causes no growth burden 
(Figure 8D). Un-induced cultures of all pyrimidine knockdowns grew like the control, 
confirming that the CRISPRi system is tight. Induced cultures, in contrast, displayed a 
wide range of growth phenotypes: knockdown of the first two enzymes of the pathway 
(PyrB and PyrC) hardly affected growth, while the PyrE knockdown caused a strong 
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growth defect. Knockdown of PyrF and PyrD impaired growth as well, but the effect 
appeared relatively late after induction of CRISPRi (around 5 hours).  
In conclusion, CRISPRi allowed us to induce dynamic decreases of protein-levels (Figure 
8B). The 5-hour delay between inducer addition and appearance of growth defects in 
the PyrF and PyrD knockdowns, suggests that the target-protein is diluted by growth 
until it reaches a critical level. In contrast, the early growth defect in the PyrE strain 
indicates that this enzyme is already expressed at a critical-level in the wild-type. This is 
consistent with previous reports about sub-optimal expression of PyrE in K12-derived E. 
coli, due to a frameshift mutation upstream of the pyrE gene 108. The comparably weaker 
growth defects of the other pyrimidine knockdowns indicated that these enzymes do 
not operate at a critical level. In other words, these enzymes are expressed at higher 
levels than absolutely necessary for UMP biosynthesis and growth (enzyme 
overabundance). However, an alternative explanation is that the sgRNAs targeting these 
genes are weaker or not functional. Therefore, we next targeted genes with several 
sgRNAs, and designed sgRNAs for all metabolism-related genes in E. coli. 
 
 
Figure 8. Dynamic knockdowns of enzymes with CRISPR interference  
(A) The CRISPR interference system consisted of an E. coli strain (YYdCas9) that has dCas9 
integrated into the genome (Lawson et al., 2017), and a single guide RNA on a plasmid (Qi et al., 
2013). dCas9 is under control of an aTc inducible Ptet promoter. The sgRNA is under control of 
a constitutive promoter. (B) Dynamic knockdown of YPet, which is integrated into the genome 
of the YYdCas9 strain. YPet fluorescence is shown for cells that express either a control sgRNA 
(black) or a sgRNA that targets YPet (orange). YPet fluorescence per OD is normalized to an un-
induced culture with the control sgRNA. The YPet knockdown was induced at time = 0 h by 
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supplementing 200 nM of aTc. Data are represented as mean, and the grey areas are ± SD (n = 
3). (C) Knockdown of an enzyme impairs growth when its concentration reaches a critical level.  
The target-enzyme is the enzyme, which is encoded by the gene that is repressed with CRISPRi. 
(D) Growth of cells expressing the control sgRNA, or sgRNAs targeting genes that encode 
enzymes in pyrimidine nucleotide biosynthesis. Expression of dCas9 was induced by 
supplementing 200 nM of aTc (blue) or dCas9 was not induced (black). Cells grew on minimal 
glucose medium in microtiter plates. Means of n = 3 cultures are shown.  
 
 
3.1.2 - E. coli metabolism is robust against CRISPRi-knockdowns of 
enzymes  
 
The latest genome-scale model of E. coli metabolism, iML1515, includes 1515 genes 119 
and we constructed sgRNAs that target these genes using array-synthesized 
oligonucleotides (Figure 2A). Per gene we designed 4 to 6 sgRNAs that target different 
loci on the coding strand.  The resulting sgRNAs were cloned in a pooled approach and 
subsequently transformed into E. coli that carried dCas9 on the genome (Figure 9A). 
Sequencing of the CRISPRi library showed that 7177 unique sgRNAs were present in the 
library and they target 1513 of the 1515 genes in the iML1515 model (Figure S3). We 
cultured the library for 13 hours on glucose minimal medium without induction of 
dCas9, which hardly altered the composition of the library (Figure S3). The stable 
composition of the un-induced library confirms again tight control of the CRISPRi system. 
Subsequently, we induced dCas9 expression and followed the library composition by 
next generation sequencing for 14 hours in intervals of 1 hour (Figure 9A). To assess 
reproducibility, we used two independent cultivations. Every two hours, the cultures 
were back-diluted into fresh medium, to avoid limitations of oxygen and nutrients. 
Growth of single CRISPRi strains was quantified as fold-change of sgRNA abundances, 
which was reproducible between the two experiments (Figure S4).  
To explore dynamic patterns in sgRNA abundances, we performed k-means clustering 
with time profiles of fold-changes (Figure 9B). The abundances of 45% of the sgRNAs 
were constant for 14 hours (cluster A). Another 30% of the sgRNAs in cluster B showed 
a slight increase, suggesting that these guides produce a small fitness advantage. The 
remaining 25% of sgRNAs in cluster C and D caused fitness defects. Cluster C represents 
mild fitness defects (average fold-change 0.5 at 14h), and cluster D stronger fitness 
3 - The metabolome buffers CRISPRi-knockdowns of enzymes in E. coli metabolism 
 34   
defects (average fold-change 0.1 after 14h). Cluster C and D include 1789 sgRNAs, which 
target in total 748 genes. Out of these 748 genes, 387 genes have at least two sgRNAs 
in cluster C and D, and we considered these genes as potential metabolic-bottlenecks. 
According to simulations with the iML1515 model, 277 of the 387 metabolic-bottleneck 
genes (71%) encode enzymes that carry metabolic flux with glucose as sole carbon 
source. 218 of the metabolic-bottleneck genes (56%) are essential for growth on glucose 
medium (Figure 9C). 89 genes (23%) are neither essential nor encode for enzymes with 
metabolic flux. Phenotypes of 9 out of these 89 genes can be explained by polar effects, 
as an essential or flux-carrying gene is encoded downstream of the targeted gene in the 
same operon. What caused fitness defects of the remaining 80 genes is unclear and it 
seems likely that these genes have previously unrecognized functions that affect fitness 
(e.g. transporters). 
Next, we identified at which time point the knockdowns created a metabolic bottleneck 
and when they became growth limiting. Therefore, we estimated a “response-time” for 
the 387 metabolic-bottleneck genes. The response time was defined as the point when 
the fold-change of sgRNA abundance was 0.8. To obtain robust estimates of response 
times we fitted sigmoidal functions to the time-courses of fold-changes (Figure 9D). 
Genes that had the shortest response times and were therefore the most sensitive 
targets in our screen were: the nrdA/nrdB operon, ppc, the ilvE/ilvD operon and fbaA 
(Figure 9D). All enzymes encoded by these genes catalyze essential reactions in primary 
metabolism: biosynthesis of deoxyribonucleotides (NrdAB), branched chain amino acids 
(IlvE and IlvD), glycolysis (FbaA) and anapleurosis (Ppc). Notably, all sgRNAs that target 
these genes had similar dynamics, suggesting that the repression efficiency of sgRNAs 
has little influence on fitness defects of sensitive targets.  
In summary, only 6 out of 1513 metabolism-related genes were very sensitive to 
knockdowns, as they had response times below 2 h. Another 32 targets had response 
times below 3 h (Figure 9E). The majority of knockdowns, however, responded late to 
induction of CRISPRi (on average 6.5 hours). This suggests that E. coli is robust against 
reducing the abundance of most metabolic enzymes and that only few enzymes (like 
NrdAB) are expressed at critical levels. Next, we wondered how strongly the abundance 
of target-enzymes decreased and which mechanisms buffered low enzyme-levels. 





Figure 9. Dynamic knockdowns of 1513 genes in the metabolic network of E. coli  
(A) A CRISPRi library targeting 1513 genes in the latest genome-scale reconstruction of E. coli 
metabolism (iML1515). Each gene was targeted with 4-6 sgRNAs, which are equally distributed 
on the coding strand. sgRNAs were cloned in a pooled approach on plasmid pgRNA-bacteria and 
YYdCas9 was transformed with the resulting plasmid library (see also Figure 8A). The library was 
induced with 200 nM aTc at time = 0 h, and cultured for 14 h in shaking flasks. The culture was 
back-diluted every 2 hours into fresh medium. Samples for next generation sequencing were 
collected every hour. (B) K-means clustering of fold-changes of 7177 sgRNAs. Time-course data 
was clustered into k = 4 clusters. Box plots represent the distribution of sgRNAs in each cluster 
per time point. (C) Venn diagram showing the overlap between 387 genes that caused fitness 
defects in the CRISPRi screen (blue, genes with at least 2 sgRNAs in cluster C and D), genes that 
are essential on glucose minimal medium (red), and genes that encode enzymes with metabolic 
flux (green). (D) Fold-changes of all sgRNAs targeting the 4 most sensitive targets in the CRISPRi 
library. Sigmoidal curves were fitted to the time-course of each sgRNA. The response time was 
defined as the time point when the fold-change of a sgRNA was 0.8.  (E) Response times of all 
387 genes that showed fitness defects in the CRISPRi screen. Shown is the average response 
time of the 2 strongest sgRNAs of each target-gene. Target-genes are grouped into metabolic 
categories according to the definition in iML1515. The name of the most sensitive target is 
shown for each category. 
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3.1.3 - CRISPRi achieves similar and specific decreases of enzyme-levels 
 
To probe how strongly CRISPRi decreases the abundance of target-enzymes, we 
measured the proteomes of 30 CRISPRi strains (Figure 10A, Figure S5). The 30 target-
enzymes included one of the most sensitive enzymes in our pooled screen, PEP 
carboxylase (Ppc) that converts PEP to oxaloacetate in E. coli. We also included PckA 
which catalyzes the reverse reaction and should have no relevance for growth on 
glucose. Other targets were distributed over the metabolic subsystems, like glycolysis 
(Pts, Pgi, PfkA, PfkB, FbaA, GapA, Eno, TpiA, PykA, PykF) and the oxidative pentose 
phosphate pathway (Zwf and Gnd). From the TCA cycle we selected the first step 
catalyzed by citrate synthase (GltA), as well as the succinate dehydrogenase complex 
(SdhABCD). Furthermore, 8 target-enzymes were in biosynthesis pathways of amino 
acids (AroA, IlvC, MetE, GdhA) and nucleotides (Adk, PyrF, PurB, PurC), or both (Prs and 
CarAB). The remaining targets were CysH in sulfur assimilation, GlmS in amino sugar 
biosynthesis and Dxs in the isoprenoid pathway. We cultured these strains in 12-well 
plates and measured their proteomes 4.5 hours after dCas9 induction, which is the time 
when growth phenotypes appeared in the first strains (Figure 10C). Each strain was 
cultured in triplicates with and without induction of dCas9, resulting in a total of 180 
proteome samples. CRISPRi downregulated specifically the target-enzymes, since 
target-enzymes decreased only in the respective knockdown and remained stable in the 
other strains (Figure 10B). The average decrease of target-enzymes was 5.1-fold, and 
decreases varied between 8-fold (PyrF) and 2.6-fold (MetE). Target-enzymes hardly 
decreased in un-induced cultures (Figure 10B), confirming that CRISPRi is tight and 
inducible. The degree of downregulation of the target-enzyme did not correlate with the 
reduction of the growth rate at the time point of sampling (Figure 10C, Figure S6), 
showing that different repression efficiencies of CRISPRi were not responsible for the 
different growth phenotypes. In summary, 4.5 h after induction of CRISPRi, target 
enzymes decreased on average 5-fold. Decreases of 19 target-enzymes caused no 
growth defect. For 10 target-enzymes growth rates declined just before the time point 
of sampling. Therefore, E. coli metabolism tolerates substantial decreases of enzyme-
levels and we next wondered which mechanisms enable this robustness. 






Figure 10. Growth defects and abundances of target-enzymes in 30 CRISPRi strains 
(A) Metabolic map showing the target-enzymes of 29 CRISPRi strains. The control strain 
expressed a sgRNA without a spacer sequence. Operon structures of the targets are shown in 
Supplementary Figure S2. (B) The bar plot shows abundances of target-enzymes in cultures with 
inducer (blue) and without inducer (grey). Data is normalized to the average enzyme-level in un-
induced cultures. The heatmap shows fold-changes of target-enzymes between induced and un-
induced cultures. Data was calculated using the means of n = 3 samples per strain, error bars 
are propagated errors. (C) Growth curves of the 30 CRISPRi strains. Uninduced cultures are 
shown in black. Induced cultures are shown in orange (200 nM aTc was supplemented at time = 
0 h). Samples for proteomics were collected at the end of the cultivation (4.5 h). Growth curves 
show means of n = 3 cultures. Background colors indicate the reduction in growth rates at the 
time of sampling. Growth rates were estimated using linear regression with the last 4 time points 
of growth curves. 
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3.1.4 - Substrates and allosteric effectors buffer decreases of enzyme-
levels 
 
To understand how E. coli metabolism compensated the ~5-fold decrease of enzyme-
levels, we measured the metabolome of the 30 CRISPRi strains. Therefore, we collected 
samples for metabolomics at the same time point as proteomics samples (4.5 hours), 
and measured 119 intracellular metabolites by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS). Metabolites that responded most strongly to knockdowns of 
enzymes were often substrates of the respective reactions (Figure 11A). In 18 out of 29 
knockdowns, the substrate increased more than 2-fold and was one of the most 
abundant metabolites. Products, in contrast, were more stable than substrates (Figure 
11A, Figure S7). In the strains with strong substrate responses, the respective products 
decreased less than 2-fold, except of the Gnd-product ribose-P and the MetE-product 
methionine. The low methionine levels in the MetE strain imply that the growth defect 
of this strain is caused by a bottleneck in the methionine pathway. We hypothesized 
that the high concentration of substrates increases the active site occupancy of 
enzymes, which in turn increases their activity. Thereby, substrates could buffer 
knockdowns of enzymes by increasing their activity.    
To test the hypothesis that substrates buffer decreases of enzyme-levels, we measured 
metabolites in the PfkA strain dynamically after induction of CRISPRi (Figure 11B). PfkA 
catalyzes an essential rate-limiting step in glycolysis, which is the phosphorylation of 
fructose-6-phosphate into fructose-1,6-bisphosphate. If fructose-6-phosphate buffers 
the decrease of PfkA, then its concentration should increase slowly and early after 
induction of the PfkA knockdown (resembling dynamics of the target-enzyme). In 
contrast, a rapid and late response of fructose-6-phosphate would indicate that the 
substrate increases because glycolysis is blocked. Indeed, the pool of hexose-
phosphates (which include fructose-6-phosphate) increased early and slowly after 
induction of dCas9 (Figure 11B), supporting our hypothesis that substrates buffer 
enzyme knockdowns. The delay of 60 minutes between induction and increase of 
hexose-phosphates matches the activation time of CRISPRi that we measured with YPet 
(Figure 11B). Thus, as soon as PfkA levels decrease, the concentration of hexose-
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phosphate starts to increase, which maintains stable glycolysis and constant levels of 
the PfkA-product fructose-1,6-bisphosphate. Therefore, dynamic metabolite responses 
to knockdowns reveal the capacity of substrates to buffer changes in enzyme-levels.  
In 4 strains allosteric effectors of the target enzyme responded most strongly to the 
knockdown (CarAB, GlmS, Ppc and Zwf, Figure 11A). Ornithine, for example, is one of 
the many allosteric effectors of CarAB and ornithine increased more than 500-fold in the 
CarAB knockdown. Thus, allosteric activation of CarAB by ornithine seems to buffer the 
knockdown of the enzyme. Similarly, knockdown of Ppc resulted in a decrease of 
aspartate (13-fold) and malate (16-fold), which are allosteric inhibitors of Ppc. The 
decreases of aspartate and malate suggested that low abundance of Ppc is doubly 
compensated by relieving two negative allosteric feedbacks. The increase of the Ppc 
substrate PEP could additionally increase the activity of the enzyme. In the GlmS and 
Zwf strain we observed a similar relieve from allosteric inhibition, because their 
respective reaction product glucoseamine-P and NADPH decreased. NADPH is the 
allosteric inhibitor of Zwf 120, and glucoseamine-P is a potent inhibitor of GlmS activity 
121. 
To confirm that allosteric regulators buffer knockdowns, we measured again the 
dynamic response of metabolites in the CarAB knockdown (Figure 11C). Similar to the 
PfkA knockdown, ornithine responded slowly and early after induction of the CarAB 
knockdown, showing that ornithine compensated decreasing CarAB levels for ~2 hours. 
After 2 hours, the concentration of arginine decreased, which is the end-product of the 
arginine biosynthesis pathway and consumes the CarAB-product carbamoyl-phosphate. 
The other pathway that uses carbamoyl-phosphate is pyrimidine nucleotide 
biosynthesis, but the pyrimidine end-products CTP and UTP did not change in the CarAB 
knockdown. The higher robustness of pyrimidine over arginine biosynthesis is probably 
due to the higher demand for amino acids than for nucleotides. Therefore, CarAB 
reached a critical level after 160 minutes, when ornithine cannot compensate the CarAB 
knockdown anymore and arginine starts limiting cell growth.  
In summary, substrates and allosteric effectors buffer decreases of enzyme-levels by 
increasing their activity. This buffering effect of the metabolome explains why E. coli 
grows normally for 2-3 hours after induction of enzyme knockdowns. Once this buffer is 
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exhausted, the reaction-product of the target-enzyme (or end-products of the target-
pathway) decrease and will eventually limit growth. We then wondered how cells 
respond to such metabolic bottlenecks at the level of enzyme-level regulation, and we 
took a closer look at the proteome data. 
 
 
Figure 11. Metabolome of 30 CRISPRi strains and dynamic metabolite responses 
(A) Intracellular concentration of 119 metabolites in the 30 CRISPRi strains. Metabolite levels 
are shown as log2 fold-change between induced and un-induced cultures. Samples were 
collected at the end of the 4.5 hours cultivations (see Figure 10C). Data are represented as mean 
(n = 2). Substrates of the target enzyme are shown in orange, products in blue, allosteric 
inhibitors in magenta and allosteric activators are green. (B) Time-course of hexose-phosphate 
(f6p) and fructose-1,6-bisphosphate (fbp) in the PfkA knockdown. Metabolite levels are 
normalized to the time point before induction. The culture was induced with aTc at t = 0h. Black 
dots are measurements in n = 2 cultures and colored dots are the mean. (C) Same as in (B) for 
ornithine (orn), arginine (arg), utp and ctp in the CarAB knockdown. Note that isomers were not 
separated: g6p and f6p is the total pool of hexose-p, r5p is the total pool of pentose-p, dhap and 
gap is the total pool dhap/gap.  
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3.1.5 - Metabolites cause a compensatory upregulation of enzymes in 
the target-pathway  
 
Proteome data showed that CRISPRi achieves specific and in average 5-fold reduction of 
the abundance of target-enzymes (Figure 10B). In 20 of 29 knockdowns the target-
enzyme was the most strongly downregulated protein among all 1506 measured 
proteins (Figure 12A). The number of significantly changed proteins (2-fold, p-test<0.05) 
had a strong correlation with the reduction in growth of the respective knockdown 
(Figure 12B). This means that strains with a growth defect had stronger proteome 
changes, whereas the proteome was stable in strains without a growth defect. The latter 
group consisted of 19 strains with less than 20 significantly changed proteins, despite 
low levels of the target-enzymes. The constant proteome in these 19 strains confirmed 
that knockdowns are buffered at the metabolome level and not at the proteome level.  
We then analyzed if the 10 strains with stronger proteome changes showed a global 
growth-dependent proteome response 65 or if proteome changes were specific. Because 
the average similarity of proteome changes between pairs of CRISPRi strains was only 
6% (Figure S8), we concluded that each knockdown caused specific proteome changes. 
As expected, knockdowns of enzymes that are close in the metabolic network caused 
more similar proteome responses. For example, the most similar proteome changes 
occurred in knockdowns of neighboring enzyme pairs: Pgi and Gnd (40% similarity), 
GapA and FbaA (39% similarity) (Figure S6). Therefore, decreasing target-enzymes to a 
critical growth-limiting level enforces specific proteome changes, which affected 
different metabolic subsystems (Figure S9). 
In five metabolic pathways we noticed a compensatory upregulation, because enzymes 
within the metabolic pathway of the target-enzyme were upregulated (Figure 12C). For 
example, all enzymes in the arginine biosynthesis pathway increased in the CarAB strain, 
demonstrating that enzyme-level regulation responds to the arginine starvation in this 
strain (Figure 11A and Figure 11C). Similarly, the methionine starvation in the MetE 
strain (Figure S10) caused a compensatory upregulation of enzymes in the methionine 
pathway. In the IlvC strain, enzymes in valine and isoleucine biosynthesis were 
upregulated. Enzymes involved in sulfur assimilation increased in the CysH strain, and 
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enzymes in aromatic amino acid biosynthesis were upregulated in the AroA strain. All of 
these upregulated pathways include the target-enzyme (which is downregulated due to 
CRISPRi). However, we observed the same response for distal target-enzymes that are 
not in the upregulated pathway. For example, methionine enzymes increased also in the 
Ppc strain, thus indicating that limiting anapleurosis has the strongest effects on 
methionine biosynthesis. Aromatic amino acid biosynthesis was also upregulated in 
knockdowns of enzymes in lower glycolysis (Eno, FbaA, GapA and TpiA). The 
knockdowns in lower glycolysis consistently caused low levels of phosphoenolpyruvate 
(PEP)(Figure S10), which is a precursor for aromatic amino acids biosynthesis. Therefore, 
limited supply of PEP for aromatic amino acid biosynthesis pathway caused the same 
compensatory upregulation as a knockdown of AroA within the pathway. 
The compensatory upregulation occurred probably at the level of transcription, because 
expression of four pathways is regulated by related transcription factors: the arginine 
pathway by ArgR, the methionine pathway by MetJ, sulfur assimilation by CysB and 
aromatic amino acid biosynthesis by TrpR. We expected that these transcription factors 
responded to the knockdown because the concentration of their allosteric regulators 
changed accordingly. Indeed, the CarAB strain had the lowest levels of arginine across 
all 30 CRISPRi strains (Figure 12C). This reduces the activity of ArgR and thereby de-
repressed expression of arginine biosynthesis enzymes in the CarAB strain. Similarly, the 
MetE and Ppc strains had low levels of S-adenosylmethionine (SAM). Low SAM levels 
reduce MetJ activity and thereby caused the compensatory upregulation of the 
methionine pathway. Changes of acetyl-serine explained upregulation of sulfur 
assimilation, and low valine levels caused upregulation of the valine and isoleucine 
biosynthesis enzymes (in this case via transcriptional attenuation). Only the response of 
the TrpR regulator, tryptophan, did not match the upregulation of enzymes in aromatic 
amino acid biosynthesis: in most strains with a transcriptional response, tryptophan 
levels did not decrease more than 2-fold and they even increased for the GapA 
condition. This suggests that additional regulators might control expression of these 
enzymes.  
To obtain additional evidence that the compensatory upregulation occurs at the level of 
transcription, we used transcriptional fluorescent reporters 122 (Figure 12D). GFP 
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expression from a MetJ regulated promoter confirmed the compensatory upregulation 
in the MetE strain. Similarly, an ArgR regulated promoter was upregulated in the CarAB 
strain. Promoter activity increased with a 2-hour delay after inducer addition. This is also 
the time when growth defects appeared in these strains, thus indicating that the 
compensatory upregulation started when the target-enzyme reached a critical level. 
In conclusion, knockdowns without growth defect had a stable proteome despite a 5-
fold decrease of target enzymes. Stronger proteome changes occurred only in strains 
that had a reduction in growth at the time point of sampling. These proteome changes 
were specific, because different proteins changed in different knockdowns. In 9 
knockdowns the responses were remarkably precise: either enzymes within the target 
pathway were upregulated (MetE, CysH, IlvC, AroA strains) or enzymes that utilize the 
reaction product of the target were upregulated (CarAB, Ppc, Eno, FbaA, GapA and TpiA 
strains). Once more, metabolites were buffering the knockdowns, in these cases by 
allosteric interactions with transcription factors (MetJ, ArgR, CysB, TrpR) or 
transcriptional attenuation (valine and isoleucine). Thus, the metabolome buffers 
knockdowns both at the level of enzyme activity and enzyme abundance.  
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Figure 12. Localized proteome changes occur in CRISPRi strains with a growth defect 
 (A) Abundance of 1506 proteins in the 30 CRISPRi strains. Protein levels are shown as log2 fold-
change between induced and un-induced cultures. Data are shown as mean (n = 3). Strains are 
ordered based on the number of differentially expressed proteins (FC>2, p-value<0.05). Blue 
dots indicate target-enzymes. Colored boxes show the reduction in growth rates at the time of 
sampling (see also Figure 3). (B) Correlation between the number of differentially expressed 
proteins (FC>2, p-value<0.05) and the reduction in growth rates for the 29 CRISPRi strains. (C) 
Fold-changes of enzymes in pathways of arginine biosynthesis, methionine biosynthesis, sulfur 
assimilation (Cys), valine/isoleucine biosynthesis and aromatic amino acids biosynthesis. 10 
CRISPRi strains with a compensatory upregulation are shown in bold. (D) Concentration of 
metabolites that are allosteric effectors of transcription factors ArgR, MetJ, CysB and TrpR. 
Valine and isoleucine regulate enzyme expression via transcriptional attenuation. Colored dots 
highlight strains that showed a compensatory upregulation of the respective pathway (boxes in 
the heatmap). (E) The MetE and CarAB knockdowns were transformed with GFP reporter 
plasmids. CarAB expressed an ArgR regulated promoter (pUA66-argE-gfp). MetE expressed a 
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MetJ regulated promoter (pUA66-metB-gfp). The fold-change of GFP/OD between induced and 
un-induced cultures is shown in green. The fold-change of OD between induced and un-induced 
cultures is shown in orange. Curves are means of n=3 cultures, shadows represent standard 
deviation. aTc was added at t = 0 h.  
  
3.1.6 - 6-phosphogluconate buffers knockdowns in the pentose-
phosphate pathway 
 
Apart from compensatory responses at the level of the target-enzyme itself, we noticed 
a third compensatory mechanism. Knockdown of Gnd in the pentose-phosphate 
pathway activated an alternative pathway, the Entner-Doudoroff (ED) pathway. This is 
consistent with previous reports about increased flux through the ED pathway in a Gnd 
knockout 123,124. The ED pathway utilizes the Gnd substrate 6-phosphogluconate, which 
accumulated in the Gnd knockdown (Figure 13A). Thus, higher expression of the ED 
pathway in the Gnd knockdown might enable overflow of the excess of 6-
phosphogluconate.  
We wondered if upregulation of the ED pathway was also caused by a metabolite. 
Transcription of the ED pathway is regulated by the two transcriptional repressors KdgR 
and GntR. While KdgR controls only the two ED enzymes (Edd and Eda), GntR has 
additional targets in uptake of gluconate (Figure 13A). The increase of an additional 
GntR target (gntT) suggested that GntR responded to the knockdown of Gnd (Figure 
13B). The activity of GntR is allosterically inhibited by gluconate 125. Therefore, we 
assumed that accumulation of 6-phosphogluconate produced small amounts of 
gluconate, which inhibited GntR and de-repressed transcription of Edd and Eda (Figure 
13C). In the un-induced Gnd strain the concentration of gluconate was 50 µM, which is 
comparable to previous measurements in E. coli 126.  Induction of the Gnd knockdown, 
led to an increase of gluconate to 184 µM. This increase in gluconate concentrations was 
probably sufficient to inhibit GntR and increase expression of the ED pathway. The 
presence of gluconate in the GND knockdown and its regulatory role in bypassing the 
oxidative PPP, reveals that gluconate acts as regulatory metabolite, which does not 
participate in metabolism but in regulation. Thus, gluconate could sense imbalances 
between the oxidative and the non-oxidative PPP, and adapt expression of the ED 
pathway accordingly. We expected that we can alter this regulation by disrupting the 
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interconversion of 6-phosphogluconate to gluconate. Indeed, deletion of gluconate 
kinase (gntK) prevented re-phosphorylation of gluconate, such that gluconate levels 
increased even further: 246 µM in the un-induced Gnd knockdown and 620 µM in the 
induced Gnd knockdown. The high gluconate levels in the gntK strain upregulated 
again the ED pathway (with and without induction of the Gnd knockdown). ED enzymes 
were even stronger overexpressed in the ΔgntK strain than in the strain with only 
knockdown of Gnd. The higher expression of ED enzymes almost prevented the 
accumulation of 6-phosphogluconate in the Gnd knockdown, confirming that the ED 
pathway enables overflow of an excess of 6-phosphogluconate. 
In summary, 6-phosphogluconate levels are sensitive to imbalances in the oxidative 
pentose phosphate pathway. The ED pathway responds to 6-phosphogluconate via an 




Figure 13. 6-phosphogluconate coordinates the Entner-Doudoroff pathway with the Pentose-
Phosphate pathway. 
(A) Metabolic map of the Entner-Doudoroff pathway (two enzymes Edd and Eda), and the 
oxidative Pentose-Phosphate pathway. GntK is a kinase that phosphorylates gluconate. 
Intracellular gluconate can derive from dephosphorylation of 6-phosphogluconate (6PG). (B) 
Fold-changes of the target-enzyme (Gnd), as well as fold-changes of all measured proteins that 
are regulated by the transcription factor GntR (Edd, Eda, GntT). Shown are induced (+) and un-
induced (-) knockdowns of Gnd in the YYsCas9 strain (blue) and the YYsCas9-gntK strain 
(green). Samples were collected after 4.5 hours cultivation in 12-well plates. Data is normalized 
to the un-induced Gnd strain. Data are means of n = 3 cultures, error bars are propagated errors. 
(C) Same as in (B) for intracellular metabolites (6PG: 6-phosphogluconate). 
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3.2 - Discussion 
 
Robustness is a fundamental feature of metabolism. A key requirement for metabolic 
robustness is that small changes in enzymes-levels have no global effects on overall 
metabolism. Otherwise, fluctuating enzyme-levels could limit metabolic flux and 
eventually cellular fitness. Theories like Metabolic Control Analysis predicted that 
metabolism is insensitive to the exact abundance of single enzymes 127–130, but have not 
measured this property at a system-level. Studies that measured flux-enzyme-
metabolite relationships at a system-level examined the impact of nutritional changes 
on metabolism of yeast 131 and E. coli 132.  But how changes of enzyme-levels affect 
metabolism is largely unexplored. In this study, we used CRISPRi to perturb the 
expression of enzymes and investigated the effects on metabolism and fitness 
systematically. 
First, we used CRISPRi to knockdown 1513 genes that are included in the latest genome-
scale model of E. coli metabolism, iML1515 119. We leveraged an inducible CRISPRi 
system for dynamic knockdowns of enzymes. Knockdown of 387 out of the 1513 
metabolism-related genes caused a fitness defect. However, fitness defects were 
delayed relative to the addition of inducer, on average 6.5 h. At this time point, enzyme-
levels should be markedly reduced, since proteome data for 29 strains showed a ~5-fold 
reduction of target-enzymes after 4.5 h. Thus, decreasing enzymes below endogenous 
levels had no immediate effect on cellular fitness. Previous reports that support this 
observation showed that metabolic enzymes are expressed in excess 133–135 and that E. 
coli keeps reserve capacities of enzymes 120,131.  
Yet, few enzymes affected fitness almost immediately after induction of CRISPRi (NrdAB, 
Ppc, IlvE and FbaA). A hypothesis is that these enzymes are rate-limiting control points 
in the metabolic network of E. coli. The most sensitive target was ribonucleoside-
diphosphate reductase (NrdAB), which seems a reasonable control point because it 
supplies deoxyribonucleotide triphosphates (dNTPs) for DNA replication. Previous work 
confirms a rate-limiting function of NrdAB, because its concentration is directly 
proportional to the rate of DNA synthesis 136. Similarly, PEP carboxylase (Ppc) supplies 
TCA-cycle precursors for biosynthesis of 10 out of the 20 amino acids (anapleurosis). 
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Thus, near-critical Ppc levels may limit overall protein synthesis. This hypothesis is 
supported by the observation that overexpression of Ppc increases the growth rate of 
E. coli 137. The high sensitivity of the ilvE/ilvD operon is probably due to the frameshift 
mutation upstream of ilvG, which causes suboptimal expression of the operon 138. 
In 30 CRISPRi strains, we measured the metabolome and proteome, in order to examine 
how decreases of enzyme-levels affected metabolism. In theory, metabolism could 
respond in two distinct ways to knockdown of an enzyme: either by global upregulation 
of the whole metabolic network, or by specific regulation of just the critical target-
enzyme. Here, we observed the latter case, since metabolome and proteome responses 
were specific and centered around the target-enzyme. For example, substrates or 
allosteric effectors of the target-enzyme were among the top responding metabolites. 
Dynamics of these local metabolite concentration changes support the hypothesis that 
they increased the activity of the target-enzymes, and that this buffered knockdowns. 
This observation matches reports about the concentration of intracellular metabolites, 
which are often near or even below binding constants of substrates or allosteric 
effectors 126,139. Moreover, the metabolome buffered knockdowns at the level of 
transcription. For example, allosteric regulators of transcription factors (arginine, SAM, 
acetyl-serine) and transcriptional attenuation by valine were responsible for a 
compensatory upregulation of enzymes in pathways that were most seriously affected 
by the knockdown. Thus, CRISPRi enforces strong responses of metabolites that interact 
with the target-enzyme directly or indirectly with regulators of the target-enzyme. From 
a methodological perspective, this highlights the large potential of CRISPR perturbations 
to infer functionally relevant interactions between metabolites and proteins, which are 
currently measured by spiking purified metabolites into cell extracts 140. 
In conclusion, our study shows that the metabolome can buffer decreases of enzyme-
levels, because enzyme-levels are higher than absolutely needed to maintain metabolic 
flux. This mechanism may ensure a high constancy of metabolic flux despite expression 
noise 141,142 or mutations that occur during the evolution of metabolic networks 143.   
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4 - Homeostasis of the Escherichia coli biosynthetic 
metabolome across different environments 
 
4.1 - Results  
 
4.1.1 - A comprehensive and systematic dataset of the E. coli 
metabolome 
 
In this work, we measured >100 hydrophilic intracellular metabolites across 16 
environmental conditions and in 3 E. coli reference strains grown on glucose, to explore 
the response of these compounds to different environments. For all conditions, we 
cultivated E. coli in three independent shake-flask batch-cultures. All cultures were 
sampled in mid-exponential phase when they reached an OD600 of 0.5, to ensure that 
oxygen and carbon sources were not limiting growth (Figure 14A, left panel). An 
exception were stationary cultures, which were sampled 1 and 2 days after entering 
stationary phase (sampling OD600 of 5.2 and 5.1, respectively). For all 19 conditions, fast 
filtration and extraction in cold acetonitrile (ACN) was used to obtain metabolite 
extracts, which we mixed with 13C internal standard and then measured by LC-MS/MS 
83,86. To obtain absolute metabolite concentrations, we first calibrated the 13C internal 
standard with authentic standards (Figure 14A, middle panel) and used the ratio of 12C 
and 13C signals in our samples for quantification. Additionally, we used the correlation 
of signals in the 12C and 13C channels to score the quality of LC-MS/MS signals. Out of 
the 147 metabolites targeted by our method, we retained for further analysis 124 
metabolites with high quality peaks (Figure 14A). For 67 metabolites we could 
determine absolute intracellular concentrations across all conditions.  
The median error between replicates was of 15 % (relative standard deviation, Figure 
14A, right panel), showing that measurements were robust and reproducible. 
Moreover, the energy charge (given as ([ATP]+0.5[ADP])/([ATP]+[ADP]+[AMP]) was high 
and remarkably constant in all growing cultures, ranging between 0.93 to 0.97 (Figure 
14A, right panel). This confirms that sampling was fast and efficient, because ineffective 
sampling and quenching would immediately affect ATP levels, which have a turn-over 
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time of few seconds 144. The low energy charge in stationary phase cells was expected 
and decreased from day 1 to day 2. Changes of the metabolomes between conditions 
were sufficient to group cells grown on minimal media, complex medium or in stationary 
phase (Figure S11). Metabolomes of cells grown under stresses as high temperature, 
low pH and high osmotic stress clustered together with metabolomes of cells grown in 




Figure 14. General overview of the experiments and data quality assessment. Cell cultures were grown 
aerobically, and sampled at OD600 of 0.5, or at 1 or 2 days of stationary phase. Quick filtration and 
quenching/extraction in ACN:methanol:H2O were applied to get the intracellular metabolites. Samples 
were analyzed by LC-MS. Median error between experiments was 15%. High energy charge (EC) values 
were calculated for all experiments, suggesting an efficient nucleotide extraction procedure.  
 
4.1.2 - The metabolome of growing cells is independent from growth 
effects 
 
Next, we compared intracellular concentrations measured in this study, with those from 
previous studies 86,145; intracellular levels of metabolites show a good match, especially 
with the more recent study, despite somewhat different cultivation conditions (Figure 
S12). After validating results from our measurments against published datasets, the next 
step was to compare it to a matching dataset of absolute protein levels of E. coli 146. In 
this case, cells were cultivated under identical cultivation conditions, resulting in 
strongly comparable growth rates (Figure S13). The key question in the comparison of 
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it has been shown for protein levels. We compared metabolite levels to the relative 
growth rates for conditions with strains in exponential growth on minimal media: 13 
metabolites (out of 124, 10.5%) displayed a growth dependent tendency (R2>0.4) (Figure 
15A, Table S3), including the known regulator of catabolite repression, cAMP 145,147. 
Metabolites with the strongest correlation with growth rates were IMP and 5-Amino-1-
(5-phospho-D-ribosyl)imidazole (CAIR), which are both precursors for the biosynthesis 
of purines (Figure S14). Interestingly, data from Kochanowski et al. (2017), for cells 
grown on different carbon sources also suggests an overall independence between 
growth rates and metabolite levels (Figure S15).  
 
Figure 15: Analysis of the metabolome dataset and comparison with the matching proteome dataset 
from Schmidt et al. 2016. (A) histogram counting metabolites and their relative correlation coefficient 
between their levels and the relative growth rates. R2 indicates the squared Person correlation 
coefficient. Most metabolites display a very low growth-dependency. (B) First singular vector (SV1, 
explaining 73.78% of the total variance) for the proteome dataset plotted against the respective growth 
rate, colors represent the different conditions based on Figure 1 (right panel). R2 indicates the squared 
Person correlation coefficient between the first singular vector and the relative growth rates. (C) First 
singular vector (SV1, explaining 59.5% of the total variance) and third singular vector (SV3, explaining 
5.31% of the total variance) for the metabolome dataset, plotted against the respective growth rate. 
Colors represent the different conditions based on Figure 1 (right panel). R2 indicates the squared Person 
correlation coefficient between the relative singular vector and the relative growth rates. The first 
singular vector displays no correlation with the growth rate, while the third singular vector, albeit having 
a weak growth dependency, accounts for a small portion of the variability in the dataset. (D) 
Distributions of relative standard deviation (RSD) for each metabolite and each protein in the respective 
datasets. The median values in the distributions were respectively of 32.9% and 34.8%. (E) Detailed 
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overview of the relative metabolite levels for all conditions normalized (in log2) to the metabolite levels 
of E. coli BW25113 grown on M9 minimal medium with glucose as sole carbon source. 
We next applied singular value decomposition 148 to deconvolute the matching 
proteomics or metabolomics datasets, for the same growth conditions mentioned 
above. In particular, we looked at which component correlates most strongly with 
growth rate values. In the case of the proteome data, the first component correlated 
strongly with growth and could explain together 73.8% of the variance in the dataset 
(Figure 15B, Table S4). In the case of the metabolome data, the first component showed 
no correlation with growth rates (Figure 15C). The third component showed the highest 
growth dependency. However, this component could explain only 5.3% of the variation 
in the data. Therefore, unlike for proteins, metabolite concentrations do not seem to be 
affected by global effects caused by changes in the growth rate. We compared then the 
variation for all metabolites or proteins: the median variation was comparable (relative 
standard deviation, 32.9% and 34.8% respectively, Figure 15D) indicating that 
metabolites and proteins have a similar degree of variation in different conditions. 
However, this variation is not driven by the same factor: protein variation is mostly 
affected by growth, unlike metabolites. Metabolite levels relative to the glucose 
condition are shown with a high resolution in Figure 15E. Metabolomes of conditions 
grown in minimal media display a limited variability, and in particular biosynthetic end-
products like amino acids and nucleotides varied in almost all cases less than 2-fold. 
Thus, we took a closer look at amino acid and nucleotide metabolism. 
 
4.1.3 - Homeostasis of amino acid metabolism 
 
To visualize the variation and identify outliers, amino acid concentrations were 
normalized to the median value of all conditions, and log2 of these values were plotted 
as an expanded boxplot (Figure 16A). Values that fell within the whiskers of the boxplot 
were grey, and outliers were plotted in a color of the matching experimental condition. 
Among all conditions, the most stable amino acid was methionine (RSD of about 13%), 
and the most variable amino acid was aspartate (RSD of 65%). Variation of amino acids 
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between conditions did not correlate with the quality of MS signal, error between the 
replicates, or the absolute level of amino acids (R2 values <0.1, Figure S16).  
We noticed that, on particular carbon sources, the concentration of individual amino 
acids was especially high. This phenomenon could in many cases be explained by the 
proximity of the entry point of the carbon source. For example, pentose phosphate 
pathway (PPP) derived phenylalanine peaked in xylose-grown cells and several amino 
acids that come from TCA cycle precursors were particularly high on fumarate (lysine, 
asparagine, glutamine, aspartate, asparagine, arginine).  Histidine was high on mannose, 
suggesting that this carbon source supports high flux through PPP. Interestingly, high 
level of phenylalanine was reached on fumarate, which is not entering the metabolism 
near PPP. This effect in fumarate grown cells can be explained by increased availability 
of aspartate for the last transamination step in phenylalanine biosynthesis 149. Similar 
effect could be responsible for high tyrosine abundance on fumarate. 
Amino acids regulate their biosynthetic pathways in two different ways: 1) feedback 
inhibition via allosteric regulation of enzymes in the pathway by its end-product, or 2) 
control of expression levels of their biosynthetic pathway via transcriptional attenuation 
or through interaction with the specific transcription factors. To visualize the free amino 
acid concentrations in the context of their regulatory role, we plotted the intracellular 
concentrations together with the known inhibitory half-saturation constants (Ki) for 
allosteric enzymes involved in their biosynthesis, and with the dissociation constants 
(Kd) of the transcription factors that control their biosynthesis (Figure 16B). 
Interestingly, the 5 most abundant free amino acids in E. coli do not directly control their 
biosynthetic enzymes/pathways neither allosterically or transcriptionally. For the 
remaining amino acids, regulatory feedback loops are described, and strikingly, their 
intracellular concentrations match well with Ki or Kd values of the proteins involved in 
the regulation. This is in agreement with previous studies 86,150,151 which found that at 
physiologically relevant concentrations of metabolites, the majority of enzyme inhibitor 
sites are occupied but far from being saturated, in contrast to substrate binding sites 
which are at or near saturation. We show that the same applies to the amino acid 
binding sites of their transcription regulators.  
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Another factor which may have an influence on the levels of intracellular concentrations 
of amino acids is their biosynthetic cost on the same substrate, in this case, glucose (Fig 
16C). Remarkably, the abundance of free amino acids seems to weakly anticorrelate 
with their biosynthetic cost, similarly to what was found for amino acid concentrations 
in mammalian cells and serum by Zhang et al. (2018). Notably, all most abundant amino 
acids for which no allosteric or transcriptional feedback is known (Glu, Asp, Gly, Ala), are 
also among the amino acids with the lowest biosynthetic cost. Therefore, energetically 
cheaper amino acids might not require a tight control on their biosynthesis, which leads 
to higher concentrations and higher availability for proteins synthesis. 
   
Figure 16. Amino acid pools in E. coli. (A) Variation of 19 amino acids in E. coli strains growing in M9 
medium supplemented with 13 different carbon sources and under stress conditions. (B) Absolute 
intracellular concentrations of free amino acids plotted together with Ki values of the allosterically 
regulated enzymes in their biosynthetic pathway (orange), and Kd values for the transcriptional factors 
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involved in regulation of their biosynthesis (grey). (C) Absolute intracellular concentrations of free amino 
acids plotted against the energetic cost of their biosynthesis (calculated by Akashi and Gujobori 2002). 
4.1.4 - Nucleotide levels remain stable despite environmental or genetic 
perturbations 
 
Next, we examined the stability end products in the form of nucleotide mono-, di- and 
triphosphates, which were remarkably constant across all conditions (Fig 17A). In case 
of ATP there was a 14% variation among exponentially growing cells. Nucleotide 
concentrations remained stable with increase in growth rate 152,153. Some of the most 
obvious outliers in nucleotide concentrations were cells grown in synthetic complex 
medium, which points to the difference between de novo synthesis and salvaging of 
adenine and uracil. For example, high UMP levels on synthetic rich medium may have 
an impact on the initial steps of de novo synthesis, as UMP is an allosteric inhibitor of 
carbamoyl phosphate synthetase 154. Interestingly, UTP levels were constant and there 
was no evidence that transcriptional attenuation of the pyrBI operon was responsible 
for the regulation of protein abundance in de novo synthesis pathway. This means that 
changes in UMP levels from 0.03 mM to 0.07 mM, might decide between de novo 
synthesis and salvaging of purine nucleotides in E. coli. Such ultrasensitive regulation has 
been show for allosteric enzymes in glycolysis 86.  
Despite end product stability, nucleotide precursor levels differed in three E. coli strains 
BW25113, MG1655 and NCM3722 grown on glucose minimal medium. While BW25113 
and MG1655 had almost identical metabolite profiles, the NCM3722 strain showed 
some striking differences. In particular, intermediates in pyrimidine nucleotide 
biosynthesis (N-carbamoyl-L-aspartate, dihydroorotic acid and orotate) were more than 
10-fold lower in NCM3722 than in the other two strains (Fig 17B). We assumed that the 
high concentration of these metabolites reflects the known frameshift mutation in 
MG1655-derived E. coli strains that causes low expression of pyrE encoded orotate 
phosphoribosyltransferase 108. The proteome data confirms this pyrimidine bottleneck 
at pyrE, because BW25113 and MG1655 have less than 50 copies of the enzyme, 
compared to 500 copies in NCM3722 (Fig 17B, upper panel, data from Schmidt et al. 
2016). While expression of pyrE was reduced in MG1655 and BW25113, other enzymes 
were upregulated, indicating a compensatory response to the pyrE bottleneck. 
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Compared to NCM3722, the enzymes catalyzing the first committed reaction (PyrI and 
B) were particularly upregulated. We assume that the chronic overproduction of 
pyrimidine intermediates in MG1655 and BW25113 is a combined effect from the 
bottleneck in the middle of the pathway (pyrE) and high enzyme levels at the entry point 
(pyrBI) (Fig 17B, upper panel). This hypothesis is supported by metabolites and protein 
levels in synthetic rich medium that contains uracil. In this condition, pyrimidines are 
synthesized via uracil salvaging, and de novo synthesis is repressed. Consequently, N-
carbamoyl-L-aspartate, dihydroorotic acid and orotate in BW25113 on synthetic rich 
medium decreased to comparable levels as in the NCM3722 strain on glucose. We also 
noticed that the bottleneck in pyrimidine nucleotide biosynthesis of MG1655 and 
BW25113 spreads into biosynthesis of purines as well. For example, levels of purine 
intermediates xanthosine-5P, IMP, and adenylosuccinic acid were 3-4 times higher in 
NCM3722 than in the other two strains on glucose (Fig 17B, lower panel).  These 
differences may reflect the close coupling of the purine and pyrimidine nucleotide 
biosynthetic pathways. Such coupling can occur simply through the common precursor 
L-aspartate, or by crosstalk at the layer of transcriptional and allosteric regulation. In 
conclusion, nucleotide biosynthetic pathways are capable of maintaining stable 
concentrations of their final products against both environmental or genetic 
perturbations. 




Figure 17. Nucleotide levels in E. coli. (A) Intracellular concentrations of nucletide mono-, di- and 
triphosphates remain stable across all conditions. Log2 was applied to median normalized values. Red line 
represents median of the 16 values, and grey box values that fall between 25th and 75th percentile. Outliers 
are depicted in color. Numbers associated to name of each metabolite represent RSD across presented 
conditions. (B) Purine and pyrimidine biosynthetic pathways. In the upper panel, protein data from 
Schmidt et al. 2016 are plotted as bars, and in the lower panel, relative intracellular concentrations are 
shown. BW25113 and MG1655 have a bottleneck caused by low levels of PyrE, which in turn results in 
upregulation of protein levels upstream and accumulation of upstream metabolites.  
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4.2 - Discussion 
 
This work investigated the intracellular metabolome of E. coli BW25113 growing on 
different substrates, under stress conditions, and in different stages of stationary phase. 
Additionally, the dataset includes the intracellular metabolome of three E. coli reference 
strains (BW25113, NCM3722 and MG1655) during exponential growth on glucose 
minimal medium. 
The type and extent of metabolome variability under steady-state growth conditions in 
substrate excess is revealed in this work. The vast majority of measured metabolites’ 
levels were not affected by a growth-rate dependency, in contrast to the proteome 
under matching conditions. A similar independence from the growth rate was observed 
for amino acids in yeast mutant libraries which grew at various rates 155. While the 
enzymatic machinery is adjusted in bulk during different growth conditions, metabolite 
levels do not change linearly with growth. The non-linear relationship between 
metabolite levels and growth/protein levels suggests that allosteric enzymes might be 
prevalent in the E. coli metabolism, as recently proposed 140. Enzymes are usually 
thought to follow Michealis-Menten kinetics, implying that reaction rates are linearly 
related to metabolite and enzymes concentrations, or only to the latter in case of high 
metabolite concentrations. Kinetics of allosteric enzymes follow instead sigmoidal 
relationships, in which small changes in concentrations of metabolites can strongly 
impact reaction rates. Previous theoretical studies have hypothesized that metabolic 
networks are insensitive to changes of enzyme concentrations 156,157, which underlines 
the importance of metabolites in control of enzymes activity, and thus in the regulation 
of the metabolic fluxes/networks. The overall degree of variation between the 
metabolome and the proteome was similar, with metabolites having a slightly higher 
variation than the proteome. A similar observation was made in a multi-omics study of 
yeast 158. In particular, key building blocks as amino acids and nucleotides showed a 
particularly low variation.  
Most of the variation in amino acids levels could be explained by the proximity of the 
entry point of the carbon source into the metabolic network. By measuring amino acids 
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concentrations systematically, we could also suggest that i) cellular bioenergetics (i.e., 
the cost of biosynthesis of a particular amino acid) may play a role in adjusting the levels 
of amino acids and determining the extent of regulation of their biosynthesis, and ii) 
highlight the importance of allosteric and “local” transcriptional control for amino acid 
biosynthesis. 
Bioenergetically cheaper amino acids, for which no allosteric or transcriptional control 
was shown, are the most abundant in the cell. It has been shown that the proteome of 
E. coli and B. subtilis has a bias towards less energetically costly amino acids 159. This 
appears to be a widely spread concept, as rapidly proliferating cancer cells optimize their 
proteome expression patterns to utilize amino acids more economically 160. In contrast, 
energetically expensive amino acids are present in low concentrations, and have tightly 
controlled de novo biosynthesis. Ki and Kd values of responsive enzymes and 
transcription factors that control amino acid biosynthesis show good match to levels of 
amino acids in the cells, pointing at the importance of combinatorial control of cellular 
metabolism 135.  
Similarly, levels of nucleotides, and in particular nucleotide triphosphates, were also 
remarkably conserved against environmental perturbations. We could show that 
despite perturbations of pathway intermediates due to mutations, end products were 
kept constant. In the case of the pyrimidine pathway, homeostasis could also be 
enforced by fluctuations in the levels of UMP, which strongly propagated at the level of 
gene expression. Interestingly, metabolites in the de novo biosynthesis of purine 
nucleotides (CAIR, IMP) showed the highest correlation with the growth rate. The purine 
de novo biosynthesis pathway plays a key role, as it is involved in the biosynthesis of 
adenylate nucleotides. ATP demand is coupled with glycolytic flux 161, and this has been 
recently confirmed by a study in which antibiotic-induced adenine starving increased 
purine biosynthesis and metabolic activity 162. While the adenylate charge ratio is kept 
constant among different growth rates and is a good indicator of metabolic activity 163, 
the absolute levels of adenylate nucleotides vary independently from the growth rate. 
This raises the question on whether intermediates upstream of AMP might be involved 
in coupling purine biosynthesis with growth. 
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In conclusion, our results shows the non-linear relationship between metabolite 
concentrations and growth in exponentially growing cells, which is not valid for 
enzymes. As the stoichiometry of metabolic enzymes of same pathways has been shown 
to be relatively conserved across evolution 164, metabolite concentrations might retain 
information on how reactions rates are adjusted at the molecular level. Precise 
measurements of larger portions of the metabolome coupled with novel methods to 
integrate multi-omics data, as machine learning 165, might help in the quest to unravel 
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5 - Conclusion and Outlook  
 
In this thesis, we focused on studying basic principles of metabolic robustness in the 
bacterial model organism Escherichia coli. We employed different methods to perturb 
metabolism and analyzed the response at the metabolite and protein level.  
First, we set to study how cells would respond to artificial localized perturbations of 
single enzymes. In Chapter 2 we explored whether CRISPRi could be a suitable method 
to cause specific perturbations of metabolism. Proteomics data supported our 
hypothesis, showing that relatively low levels of a heterologously expressed dCas9 do 
not affect cell physiology and can enforce specific and dynamic reductions in abundance 
of a targeted enzyme. In Chapter 3 we applied this methodology at different scales, in 
different experimental setups and with different readouts. We perturbed the whole 
metabolic network of E. coli, observing that the bacterium is remarkably robust against 
perturbations of single enzymes. Cells with progressively reduced enzyme levels could 
grow optimally for hours, before encountering a growth defect (response time). This 
result suggests that most enzymes are expressed at higher levels than strictly necessary 
for optimal growth (enzyme overabundance). This robustness principle was previously 
postulated in theoretical and computational studies 55,166 and proven for amino-acids 
biosynthesis pathways 135. Enzyme overabundance has probably evolved to allow cells 
to resist environmental perturbations. However, which optimization principles guide 
this phenomenon and how it differs between different enzymes remain as open 
questions. 
A thorough characterization of enzyme overabundance could be exploited for the 
construction of minimal cells from the perspective of gene expression. The E. coli 
proteome covers 55% of the whole dry weight of the cell 167, and metabolic enzymes 
cover 47.1% of the whole proteome 146. By artificially reducing these fractions to the 
minimum necessary, cells could consume less nutrients to maintain and grow their 
biomass under controlled conditions with limited environmental perturbations. This 
could have important applications for industrial biotechnology, as production yields of 
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such synthetic strains could be increased. In this context, investigating overabundance 
of other proteomic fractions could also be of interest. 
Another interesting observation derived from the CRISPRi experiments was that 
intracellular concentrations of substrates and allosteric effectors of the targeted 
enzymes were consistently strongly perturbed. By observing the composition of the 
metabolome over time, we hypothesize that these particular variations in metabolite 
concentrations, upon reduction of levels of an enzyme, might increase its activity 
maintaining optimal metabolic flux and cell growth. We could also observe that 
regulation of enzyme abundance, through known metabolite-transcriptional regulation 
feedbacks, was triggered only when the targeted enzyme reached a critically low level 
causing a growth phenotype (response time). Normally, cells should be able to increase 
levels of the critical enzymes due to these regulatory feedbacks. However, in our 
experimental setup, transcriptional upregulation could not overcome the knockdown 
enforced by the dCas9 complexes.  
These combined results suggest a further robustness principle of metabolism, in which 
the metabolome provides a buffering effect that can counter a certain range of 
perturbations of enzyme levels. When this range is crossed, or in other words, when the 
metabolome buffering effect is exhausted, then specific gene expression regulatory 
circuits are activated to restore optimal enzyme levels. As cells are already expressing 
higher enzyme levels than strictly needed, specific gene regulatory mechanisms 
probably serve the purpose of countering strong genetic or dynamic environmental 
perturbations. Interestingly, due to the metabolome buffering effect, CRISPRi mediated 
enzyme knockdowns could be exploited to identify, in vivo, metabolites that regulate 
enzyme activity as allosteric effectors. If such identification of allosteric effectors could 
be proven at a systems level, it could be argued that metabolite concentrations are a 
driving evolutionary force for the emergence of allosteric regulation. 
In Chapter 4 we perturbed microbial metabolism by growing cells in different conditions 
and measuring the metabolome at steady-state. We observed that, when cells grow 
exponentially, key metabolites as amino-acids and nucleotides are kept at constant 
levels. Robustness in levels of these key metabolites is achieved by combined activities 
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of allosteric and transcriptional regulatory feedbacks 135. We then compared our data 
with a matching published dataset of protein abundances in E. coli 146. Unlike for 
proteins, we could observe that metabolite levels are not affected by growth effects. 
This fact suggests that absolute concentrations of metabolites within cells follow 
different optimality principles than proteins. A hypothesis could be that the 
metabolome maintains its independence from growth to enforce its buffering effect. 
Enzyme levels are tuned in bulk at different growth rates, meaning that their 
stoichiometry is kept constant. In fact, enzyme stoichiometry is quantitatively conserved 
even across evolution 164. However, enzymes are known to possess a wide range of 
kinetic parameters 168 and their activity in vivo might generally not increase linearly with 
substrate concentrations, as most enzymes are thought to be heavily regulated at the 
allosteric level 140. Therefore, growth independent changes in metabolite concentrations 
could be necessary to enable the buffering effect for enzymes that have a different range 
of kinetic parameters, but are co-expressed in bulk. 
Measuring metabolite concentrations in large numbers of steady-state cultures could 
contain valuable information regarding enzyme kinetics. As an example, in yeast it has 
been shown that the precise measurement of amino acids levels in thousands of gene 
knockouts could lead to infer the deleted gene identity based on the metabolite 
signature 155. In this context, advancements in machine learning methods for multi-
omics data analysis and metabolic kinetic modeling will play a fundamental role in 
deconvoluting complex datasets 165,169. Being able to obtain kinetic information from 
steady-state omics data would be a considerable advantage, as the construction of large 
datasets of dynamic data is still experimentally challenging. To this end, further 
improvements in precision and coverage of MS-based metabolomics and automation of 
experimental procedures will play an important role. 
Overall, in this thesis we have applied a systems biology approach to investigate 
microbial metabolic robustness. We could observe two main mechanisms which render 
microbes robust against perturbations of metabolism: the constitutive overexpression 
of metabolic enzymes (overabundance) and specific changes in metabolite levels that 
prevent and precede specific regulation of enzyme abundance (metabolome buffering 
effect).  
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Metabolism is widely conserved among living beings. Therefore, it is possible that such 
principles could be conserved in more complex, fast growing living systems, in example 
cancer cells. Moreover, bacteria are extensively used in industrial biotechnology, and 
industrial strains often require the engineering of metabolic pathways. Hence, 
understanding metabolic robustness in this context, and how it can be possibly 
manipulated, could lead to more efficient industrial strains. In general, increasing our 
understanding of biological principles from a systems perspective has a fundamental 
role in enabling robust and reproducible biological engineering of synthetic organisms, 
known also as synthetic biology (Figure 18). In turn, the utilization of synthetic 
organisms for basic studies, can lead to insights on how biological systems function, as 
showcased in this thesis. Therefore, the combination of systems and synthetic biology 
approaches is of great importance for scientific discovery and technological 
advancement. In the context of industrial biotechnology, these combined 
methodologies will have an important impact for the transition towards a sustainable 
bio-based economy. 
 
Figure 18: Scheme highlighting the mutual relationship between systems and synthetic biology. Systems 
biology tries to reverse engineer living beings by understanding how the ensemble of biological parts 
function as a system. The insight provided, is used by synthetic biology to forward engineer organisms 
that can be studied by systems biology approaches. This mutual relationship can lead, from both sides, to 
novel scientific discoveries and technological advancements. 
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6 - Materials and Methods 
 
 
6.1 - Construction and cultivation of CRISPRi strains 
 
The following paragraphs (6.1) refer to strains and experimental procedures showcased 
in Chapters 2 and 3. 
 
6.1.1 - Construction of arrayed strains 
 
E. coli DH5α was used for plasmid construction. E. coli BW25933 was transformed with 
pdCas9-bacteria to obtain the pCRISPRi strain. sgRNA guide sequences were designed 
with Matlab scripts by searching for the first NGG PAM site on the coding strand for each 
gene of interest. Adjacent to PAM sites, 20 nt regions were selected. Most plasmids were 
synthesised (Doulix srl). Alternatively, 150 nt oligonucleotides were synthesized (Agilent 
Technologies). The 150 nt sequences contained the 20 nt sgRNA guide sequences and 
65 nt flanking regions homologous to the pgRNA-bacteria backbone. Oligonucleotides 
were amplified with 15 cycles of PCR amplification. The pgRNA-bacteria backbone 
(containing the nontargeting spacer sequence 5’-AACTTTCAGTTTAGCGGTCT-3’) was 
linearized by PCR and amplified oligonucleotides were inserted with Gibson assembly. 
All plasmids were verified by sequencing. pCRISPRi and E. coli YYdCas9 were then 
transformed with the relative pgRNA-bacteria plasmids. 
For CRISPRi of YPet,  the sgRNA targeted lacZ, the first gene of the operon that includes 
YPet 104. The plasmid pUA66 was used to measure promoter activity 122. The ΔgntK 
mutant was constructed by P1 Phage transduction of YYdCas9 using the donor strain 
JW3400 (ΔgntK) from the KEIO collection 170. The resulting strain was cured from the 
kanamycin resistance gene included in the transduction cassette. The deletion of gntK 
was confirmed by sequencing. The final YYdCas9_ΔgntK strain was transformed with the 
pgRNA-gnd plasmid. 
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6.1.2 - Construction of the CRISPRi pooled library 
 
sgRNA guide sequences were designed with Matlab scripts by searching for 4 to 6 
equally distributed NGG PAM sites on the coding strand of each gene in the iML1515 
model 119. Adjacent to PAM sites, 20 nt regions were selected. 150 nt oligonucleotides 
were synthesized (Agilent Technologies). The 150 nt sequences contained the 20 nt 
sgRNA guide sequences and 65 nt flanking regions homologous to the pgRNA-bacteria 
backbone. Oligonucleotides were amplified with 15 cycles of PCR amplification. The 
pgRNA-bacteria backbone (containing the nontargeting spacer sequence 5’-
AACTTTCAGTTTAGCGGTCT-3’) was linearized by PCR and amplified oligonucleotides 
were inserted with Gibson assembly. The Gibson assembly product was purified and 
subsequently transformed into electrocompetent E. coli YYdCas9 cells. Plating on four 
Petri dishes with 15 cm diameter resulted in approximately 9.9 × 107 colonies. Colonies 
were washed from the plates, pooled and stored as glycerol stocks. 
 
6.1.3 - Media 
 
Cultivations were performed with LB medium or M9 minimal medium with glucose as 
sole carbon source (5 g L-1). M9 medium was composed by (per liter): 7.52 g Na2HPO4 2 
H2O, 5 g KH2PO4, 1.5 g (NH4)2SO4, 0.5 g NaCl. The following components were sterilized 
separately and then added (per liter of final medium): 1 mL 0.1 M CaCl2, 1 mL 1 M 
MgSO4, 0.6 mL 0.1 M FeCl3, 2 mL 1.4 mM thiamine-HCl and 10 mL trace salts solution. 
The trace salts solution contained (per liter): 180 mg ZnSO4 7 H2O, 120 mg CuCl2 2 H2O, 
120 mg MnSO4 H2O, 180 mg CoCl2 6 H2O. For strains transformed with pgRNA-bacteria 
plasmids, 100 μg mL-1 ampicillin (Amp) was added to the media. Additionally, pCRISPRi 
strains were cultivated in the presence of Chloramphenicol (35 μg mL-1). To induce 
expression of the dCas9 protein in the YYdCas9 strain, aTc was added to a final 
concentration of 200 nM. 
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6.1.4 - General Cultivation conditions 
 
Strains of interest were first recovered from glycerol stocks on fresh LB plates. Colonies 
were then inoculated into liquid LB cultures for 4-5 hours and then diluted 100x into 
5mL of m9 minimal medium overnight. Precultures were then diluted into 96-well plates 
or flasks at different starting concentrations. For induction of dCas9 expression 200nM 
of aTc were added at the start of the the relative cultures. 96-well plates were then 
incubated in a plate reader (Biotek Synergy) for 24 hours measuring OD600. Flasks were 
incubated in a shaking incubator and samples for proteomics were obtained by 
temporarily moving the cultures in a thermostatic hood. All cultivations were carried out 
under shaking conditions at 37°C. 
 
6.1.5 - Cultivation conditions for OD and YPet-, GFP-fluorescence 
measurements 
 
Single colonies on LB+Amp agar plates were transferred into 5 mL LB+Amp liquid 
cultures. The LB pre-cultures were used to inoculate a second pre-culture in M9 medium 
that was incubated overnight in 13 mL culture tubes under shaking at 37°C. M9 pre-
cultures were diluted in 150 L M9 medium (1:50) and incubated in 96-well plates. Every 
strain was cultured in triplicates with and without addition of aTc to the M9 main culture 
(aTc was not added to pre-cultures). For YPet fluorescence measurements, 0.1 mM IPTG 
was added to pre-cultures and main cultures to induce YPet expression. Optical density 
at 600 nm and YPet fluorescence (excitation 510 nm, emission 540 nm) was measured 
every 5 min using a plate reader (BioTek, Synergy). For GFP measurements, GFP 
fluorescence (excitation 490nm, emission 530nm) was measured in 10 min intervals 
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6.1.6 - Cultivation conditions for metabolome and proteome sampling 
 
Single colonies of strains of interest were transferred into liquid 5 mL LB+Amp from fresh 
LB+Amp plates, and then re-inoculated in M9 medium overnight in 13 mL culture tubes 
under shaking at 37 °C. For metabolomics and proteomics sampling, M9 pre-cultures 
were adjusted to a starting OD600 of 0.05 into 12-well plates, with 2 mL of medium in 
each well. Strains were cultivated in triplicates with or without aTc, added at the 
beginning of the culture. Optical density at 600nm was measured every 10 min using a 
plate reader (Tecan, Spark) for c.ca 4.5 h. Plates were then rapidly transferred to a 
thermostatically controlled hood at 37 °C and kept shaking during the sampling 
procedure. For dynamic metabolomics, M9 pre-cultures were adjusted to a starting 
OD600 of 0.05 in a beaker containing 50 mL of medium and a magnetic stirrer. Beakers 
were incubated with 400 rpm magnetic stirring in a thermostatically controlled hood at 
37 °C.  
 
6.1.7 - Cultivation conditions of the pooled CRISPRi library 
A preculture of 50 mL LB+Amp was inoculated with 500 µL of the pooled CRISPRi strain 
library from a glycerol stock and incubated at 37 °C for 5 hours. From the LB culture a 
second preculture in M9 was inoculated with a dilution of 1:10000 and incubated for 13 
hours. After 13 hours the M9 preculture was in exponential phase and it was used to 
inoculate two main cultures with an initial OD of 0.05 in shaking flasks containing 100 
mL of M9 with 200 nM of aTc to induce expression of dCas9. Every hour, OD was 
measured and samples for sequencing were collected. Every 2 hours, the culture was 
back-diluted to an OD of 0.05 with fresh and prewarmed M9 containing 200 nM of aTc. 
Samples were centrifuged to precipitate the cells and plasmids were extracted with the 
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6.2 - Cultivation of E. coli under different environmental 
conditions 
 
The following paragraphs (6.2) refer to strains and experimental procedures showcased 
in Chapter 4. 
 
6.2.1 - Strains and growth conditions 
 
Escherichia coli strains BW25113, MG1655 and NCM3722 were used (Baba et al. 2006, 
Bachmann et al. 1996, Brown and Jun 2015). Experimental conditions were matching 
those from Schmidt et al. (2016). M9 minimal medium was prepared in the following 
way: to 800 ml of water, 200 ml of 5 × base salt solution (211 mM Na2HPO4, 110 mM 
KH2PO4, 42.8 mM NaCl, 56.7 mM (NH4)2SO4, in H2O, autoclaved), 10 ml of trace 
elements (0.63 mM ZnSO4, 0.7 mM CuCl2, 0.71 mM MnSO4, 0.76 mM CoCl2, in H2O, 
autoclaved), 1 ml 0.1 M CaCl2 solution, 1 ml 1 M MgSO4 solution, 2 ml of 500 × 
thiamine solution (1.4 mM) and 0.6 ml 0.1 M FeCl3 solution (all in in H2O) were added. 
The resulting solution was filled up to 1 l with water and filter sterilized. 40 x stock 
solutions of individual carbon sources were prepared in H2O and pH was set to 7 by 1 M 
NaOH or HCl. Final concentrations of individual carbon sources were: sodium acetate, 
3.5 g/L, disodium fumarate, 2.8 g/L, galactose 2.3 g/L, glucosamine 2.1 g/L, glycerol 
2.2 g/L, sodium pyruvate 3.3 g/L, disodium succinate hexahydrate, 5.7 g/L, glucose, 
fructose, mannose and xylose 5 g/L. For salt stress experiment, NaCl was added to M9 
to a concentration of 50 mM; for pH stress, M9 pH was set to 6.0 by titrating with HCl. 
Amino acids were dissolved in M9 to following concentrations: alanine 1.0 mg/L (0.0 
mM), adenine 10.2 mg/L (0.1 mM), arginine 51.1 mg/L (0.3 mM), asparagine 1.6 mg/L 
(0.01 mM), aspartic acid 81.8 mg/L (0.6 mM), cysteine 1.2 mg/L (0.01 mM), glutamate 
15.2 mg/L (0.1 mM), glutamine 13.9 mg/L (0.1 mM), glycine 0.4 mg/L (0.01 mM), 
histidine 20.5 mg/L (0.1 mM), isoleucine 51.1 mg/L (0.4 mM), leucine 102.3 mg/L (0.8 
mM), lysine 51.1 mg/L (0.4 mM), methionine 20.5 mg/L (0.14 mM), phenylalanine 
51.1 mg/L (0.3 mM), proline 5.2 mg/L (0.05 mM), serine 9.2 mg/L (0.1 mM), threonine 
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102.3 mg/L (0.9 mM), tryptophan 51.1 mg/L (0.3 mM), tyrosine 51.1 mg/L (0.3 mM), 
valine 143.2 mg/L (1.2 mM) and uracil 20.5 mg/L (0.2 mM). To this synthetic complex 
medium, glycerol was added (final concentration 2.2 g/L). All chemicals used were 
from Sigma-Aldrich. 
 
6.2.2 - Cultivation and growth rates 
 
Cryostocks kept at -80°C were streaked out on LB plates (Luria Miller, Carl Roth) and 
incubated overnight at 37°C. Single colony was picked and inoculated into M9 preculture 
(7.5 ml in 100-ml flask), which was grown 6 - 10h, to be subsequently diluted in another 
equal preculture. From the second preculture growing exponentially, main culture was 
inoculated at an approximate OD 0.05 in 35 ml in 500-ml non-baffled wide-neck shake 
flask, covered by a 38-mm silicone sponge closure (BellCo glass). Cultivations were 
performed at 37 °C, 200 rpm and 5-cm shaking diameter (Infors HT Minitron), except 
for the heat-stressed cells which were grown at 42 °C. Growth was monitored by 
measuring the OD600.  Specific growth rates (μ) were calculated through linear 
regression of the plots of ln(OD600) versus time during the exponential growth phase. 
Further information on the growth rates and comparison with the results from the 
proteomics study can be found in Supplementary Table S1. Stationary cells were 
cultivated 24 and 48 h after reaching stationary phase.  
 
6.2.3 - Sampling and sample preparation for metabolomics 
 
All growing cultures were sampled at an OD600 of approximately 0.5. Further information 
on the OD values and sampling volumes can be found in Supplementary Table S1. For 
the intracellular metabolites, 2 ml of whole cell broth was vacuum-filtered through filter 
membrane (Durapore 0.45 µM Whatmann). Filter containing cells was quickly immersed 
into 1 ml of ACN:methanol:H2O (40:40:20) at -20°C. Extraction was performed overnight 
at -20°C. Cell extracts were then centrifuged at –9°C, 13 000 rpm and 20 min 
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(HeraerusTM Pico 17TM ThermoScientific). An aliquot of the supernatant was 
immediately mixed with 13-C internal standard in equal proportion.  
 
6.2.4 - Next Generation Sequencing and Data Analysis 
 
To generate the DNA fragments of target regions, which are compatible with Illumina 
sequencing, a two-step PCR approach was used. First, a 300 bp fragment including the 
sgRNA sequence and the flanking regions has been amplified using Q5 polymerase (New 
England Biolabs, USA) and specific oligonucleotides binding at the target region 
(NGS_F2_adapter and NGS_R2_adapter, Supplementary Table 3). As template, 150 ng 
of the purified samples were used in a 50 μl PCR reaction with the following settings: 98 
°C for 30 s, 12 cycles of 98 °C for 10 s, 65 °C for 30 s and 72 °C for 15 s; final extension at 
72 °C for 5 min. Afterwards, the PCR products were purified with a NucleoSpin Gel and 
PCR Clean-up Kit (Macherey-Nagel, Germany) and eluted in 20 µL water. In the second 
PCR, when different pairs of indexes (i5 and i7) were added to each amplicon, Phusion 
High- Fidelity DNA Polymerase (New England BioLabs, USA) was used with the following 
conditions: 98 °C for 30 s; 12 cycles of 98 °C for 10 s, 55 °C for 30 s and 72 °C for 20 s; 
final extension at 72 °C for 5 min. 4 ng of template was used in a final volume of 20 µL. 
Cleanup of the PCR products was done with AMPure XP beads (Beckman Coulter). All 
samples were run on a Bioanalyzer with an Agilent High Sensitivity DNA Kit (Agilent, USA) 
to analyze their composition. Next, 100 ng of each sample was pooled and the 
concentration of the pooled samples was measured using the Qubit dsDNA HS Assay on 
a Qubit 2.0 Fluorometer. The pooled samples were diluted, denatured and loaded on a 
MiniSeq High Output Cartridge following the manufacturer’s instructions. To guarantee 
sufficient sequence diversity, 50% PhiX was spiked into the samples. Single-end reads 
provided sequences, which were mapped to the sgRNAs in the CRISPRi library using a 
Matlab Script. Read counts were calculated with single-end sequencing reads that 
matched to sgRNA guide sequences in the CRISPRi reference library. Read counts per 
sgRNA (readsi) were normalized to the total number of read counts per sample 
(readstotal) to obtain frequencies of sgRNAs. Frequencies were normalized to the first 
time point (t = 0h) to calculate fold-changes. 
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6.3 - Metabolomics measurements 
 
Cultivations were performed as described above. Culture aliquots were vacuum-filtered 
on a 0.45 μm pore size filter (HVLP02500, Merck Millipore). Filters were immediately 
transferred into a 40:40:20 (v-%) acetonitrile/methanol/water extraction solution at -20 
°C. Filters were incubated in the extraction solution for at least 30 minutes. 
Subsequently, metabolite extracts were centrifuged for 15 minutes at 13,000 rpm at -9 
°C and the supernatant was stored at -80 °C until analysis. Metabolite extracts were 
mixed with a 13C-labeled internal standard in a 1:1 ratio. LC-MS/MS analysis was 
performed with an Agilent 6495 triple quadrupole mass spectrometer (Agilent 
Technologies) as described previously 83.  
Additionally, for measurments of strains cultivated under different environmental 
conditions, we applied 2 separate LC methods for nucleotide and keto-acids 
determination. Nucleotides in cell extracts were measured by dedicated basic 
conditions method, in which LC parameters were kept. Keto acids were derivatized prior 
to measurement, using 50 µM freshly prepared phenylhydrazine (Sigma-Aldrich) 
(Zimmermann et al. 2014). Reaction was left to proceed for 1 h at -20°C in 
ACN:methanol:H2O solvent (40:40:20). Since the concentration of oxaloacetate and 
glyoxylate was too low for MS detection, derivatized mixture was concentrated 
approximately 10 times by drying in speedvac (RVC 2-25 Cdplus, Martin Christ) and 
separated using the acidic method with standardized LC run settings.  
An Agilent 1290 Infinity II UHPLC system (Agilent Technologies) was used for liquid 
chromatography. Temperature of the column oven was 30°C, and the injection volume 
was 3 μL. LC solvents in channel A were either water with 10 mM ammonium formate 
and 0.1% formic acid (v/v) (for acidic conditions), or water with 10 mM ammonium 
carbonate and 0.2% ammonium hydroxide (for basic conditions). LC solvents in channel 
B were either acetonitrile with 0.1% formic acid (v/v) (for acidic conditions) or 
acetonitrile without additive (for basic conditions). LC columns were an Acquity BEH 
Amide (30 x 2.1 mm, 1.7 μm) for acidic conditions, and an iHILIC-Fusion(P) (50 x 2.1 mm, 
5 μm) for basic conditions. The gradient for basic and acidic conditions was: 0 min 90% 
B; 1.3 min 40 % B; 1.5 min 40 % B; 1.7 min 90 % B; 2 min 90 % B. The ratio of 12C and 13C 
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peak heights was used to quantify metabolites. 12C/13C ratios were normalized to OD at 
the time point of sampling. Absolute concentrations of gluconate were determined from 
12C peak heights and an external calibration with an authentic standard. A specific cell 
volume of 2 μL mg-1 was used to calculate the cell volume. 
Quantification of selected primary metabolites was performed by using 12C/13C ratio 
described by Bennett et al. (2008). The 13C internal standard was quantified by using 
metabolite standards of known concentration at 10 different dilutions (Figure S6). Data 
analysis was performed using Matlab 2016b and 2017b. Obtained MS data was 
converted into a text file using MSConvert (Chambers et al. 2012). Further data analysis 
was performed by in-house Matlab-based software (Guder et al. 2017).   
For normalization of intracellular metabolites, we followed an assumption that OD-
specific cell volume is constant 171. It is also worth to mention that in the case of 
metabolite being present in the medium, like in the case of amino acids in synthetic 
complex medium, the intracellular concentrations of these were not taken into account, 
because they are probably influenced by the extracellular amino acids. 
 
6.4 - Proteomics sample preparation and measurement 
 
Cultivations were performed as described above. Culture aliquots were transferred into 
2 mL reaction tubes and washed two times with PBS buffer (0.14 mM NaCl, 2.7 mM KCl, 
1.5 KH2PO4, 8.1 Na2HPO4). Cell pellets were resuspended in 300 μL lysis buffer containing 
100 mM ammonium bicarbonate, 0.5 % sodium laroyl sarcosinate (SLS). Cells were lysed 
by 5 minutes incubation at 95 °C and ultra-sonication for 10 seconds (Vial Tweeter, 
Hielscher). Cells were again incubated for 15 minutes with 5 mM Tris(2-
carboxyethyl)phosphine (TCEP) at 90°C followed by alkylation with 10 mM 
iodoacetamide for 15 minutes at 25 °C. To clear the cell lysate, samples were centrifuged 
for 10 minutes at 15,000 rpm and the supernatant was transferred into a new tube. 
Protein samples were quantified using a BCA Protein Assay kit (Thermo Fisher Scientific). 
For each sample, 50 μg of proteins was aliquoted to new tubes, volumes were adjusted 
and cell lysates were digested with 1 μg trypsin (Promega) overnight at 30°C. SLS was 
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removed by precipitation. Therefore, trifluoroacetic acid (TFA) was added to a final 
concentration of 1.5 % and incubated at room temperature for 10 minutes. After 
centrifugation (10 minutes at 10,000 rpm), the supernatant was used for C18 
purification of peptides using Micro SpinColumns (Harvard Apparatus). The purified 
peptide solutions were dried and resuspended in 0.1 % TFA. The concentration of 
peptides in the samples was measured with a colorimetric peptide assay (Pierce™ 
Quantitative Colorimetric Peptide Assay, Thermo Fischer Scientific). Analysis of peptides 
was performed by with a Q-Exactive Plus mass spectrometer coupled to an Ultimate 
3000 RSLC nano with a Prowflow upgrade and a nanospray flex ion source (Thermo 
Scientific). Peptide separation was performed on a reverse-phase HPLC column (75 μm 
x 42 cm) packed in-house with C18 resin (2.4 μm, Dr. Maisch GmbH, Germany). The 
following separating gradient was used: 96 % solvent A (0.15% formic acid) and 4 % 
solvent B (99,85 % acetonitrile, 0.15 % formic acid) to 30 % solvent B over 60 minutes at 
a flow rate of 300 nL/min. The data acquisition mode was set to obtain one high 
resolution MS scan at a resolution of 70,000 full width at half maximum (at m/z 200) 
followed by MS/MS scans of the 10 most intense ions. To increase the efficiency of 
MS/MS attempts, the charged state screening modus was enabled to exclude 
unassigned and singly charged ions. The dynamic exclusion duration was set to 30 
seconds. The ion accumulation time was set to 50 ms for MS and 50 ms at 17,500 
resolution for MS/MS. The automatic gain control was set to 3x106 for MS survey scans 
and 1x105 for MS/MS scans. Label-free quantification (LFQ) of the data was performed 
using Progenesis QIP (Waters), and for MS/MS searches of aligned peptide features 
MASCOT (v2.5, Matrix Science) was used. The following search parameters were used: 
full tryptic search with two missed cleavage sites, 10ppm MS1 and 0.02 Da fragment ion 
tolerance. Carbamidomethylation (C) as fixed, oxidation (M) and deamidation (N,Q) as 
variable modification. Progenesis outputs were further processed with SafeQuant. The 
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6.5 - Data analysis 
 
6.5.1 - Quantification and Statistical Analysis 
 
Statistical analysis was performed using custom Matlab scripts. The number of replicates 
(n) of each experiment can be found in the respective figure caption. In growth assays, 
n represents the number of independent microtiter plate cultures. For proteomics and 
metabolomics n represents the number of independent microtiter plate or shake flask 
cultures. Three replicates were used for metabolomics, and one of the three replicates 
was removed based on its Euclidean distance from the other two replicates. The 
remaining two replicates were used to calculate means. This removed outliers in the 
metabolome data set, which can occur due to the high sensitivity of the metabolome 
during sampling. In the proteomics datasets, proteins with an average variability 
between triplicates higher than 20% were removed. Significant proteins were defined 
with a two-fold cut-off and a p-value<0.05 for a two-sample t-test. Similarity of 
proteomes was obtained calculating the Jaccard index of significantly differentially 
expressed proteins.  
 
6.5.2 - Constraint-based modelling 
 
Genes that encode enzymes with metabolic flux during growth on glucose were 
determined with Flux Balance Analysis (FBA). The E. coli iML1515 metabolic model was 
downloaded from BiGG Models http://bigg.ucsd.edu/ 172 and FBA simulations were 
applied using COBRApy 173 with parameters as described in Monk et al., 2017. 
 
6.5.3 - Singular value decomposition 
 
Singular value decomposition 148 was applied as previously described 145, transforming 
the data into log space and using the svd function in Matlab. 
 
6 - Materials and Methods 

































Figure S1: Behaviour of a YYdCas9 strain with interference of ftsZ, in comparison to the YYdCas9 control 
strain. OD600 in log scale and growth rate over time, lines represent average of replicates (n=3), grey 
shadowed areas represent standard deviation. Only when inducing interference, the ftsZ strain displays 
a growth phenotype, while in the uninduced state the strain grows comparably to the control. 
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Figure S2: Differences in proteome data when normalizing for fold-change against different 
conditions. The top plot showcases proteomes of all conditions normalized to the un-induced 
control strain. The middle plot showcases proteomes normalized to the relative un-induced 
strain at T1. The bottom plot represents proteomes normalized against the relative un-induced 
strain at the relative time-point. The tables on top of the plots represent the number of 
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Figure S3. Details of the raw deep-sequencing data. 
(A) Distribution of 7177 sgRNAs in the initial CRISPRi library. Shown are read counts after 
transformation of plasmid into E. coli YYdCas9 and cultivation on LB medium.  
(B) Fold-change between sgRNA abundances after 13 hours cultivation on M9 glucose medium 
(without induction), relative to the initial CRISPRi library. Fold-change is plotted against read 
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log2 fold-change (replicate 2) 
 
Figure S4. Fold-changes of sgRNA abundances in the two competition experiments. Each plot 






























Figure S5. Related to Figure 10. 
(A) Operon structure of the 29 target-genes, based on the Ecocyc database (ecocyc.org). The 
approximate locus that is targeted by sgRNAs is indicated in red (the exact targeted sequences 
are available in Supp Table 9). The genes in grey encode proteins that were measured. (B) Fold-
changes of enzymes encoded by genes in the operons shown in (A). Data was calculated using 
the means of n = 3 samples per strain.  
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Figure S6. Related to Figure 10.  
Reduction in growth rates of 29 CRISPRi strains is shown on the y-axis. The reduction of the 
target protein is shown on the x-axes. 
 
 
Figure S7. Related to Figure 11.  
Fold-changes of substrates and products in CRISPRi strains (in which both metabolites were 
measured). MetE has two substrates. PurB catalyzes two reactions. Data are represented as 
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Figure S8. Similarity between the differentially expressed proteins of the 30 measured 
proteomes. 
(A) Similarity matrix of differentially expressed proteins (FC=2, p-value<0.05) of the 30 measured 
proteomes. Similarity is defined as the Jaccard similarity index. Highest similarity was calculated 
for the pairs (in order) Gnd-Pgi (40%), FbaA-GapA (38.89%), Eno-Ppc (34.27%), AroA-CysH 
(33.33%), CysH-Eno (32.26%), AroA-Eno (30.51%). (B) Distribution of Jaccard similarity indexes 
between differentially expressed proteins in different strains. The median similarity for the 
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Figure S9. Related to Figure 12.  
Heatmaps show log2 fold-changes of proteins between induced and un-induced cultures. Data 
was calculated using the means of n = 3 samples per strain. Data is organized based on metabolic 
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Figure S10. Related to Figure 12. 
Fold-changes of methionine (met) and phosphoenolpyruvate (PEP) in the 30 different 
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Figure S11: agglomerative hierarchical clustering of the condition-dependent metabolome 
dataset. Data matrix is normalized along rows (metabolites) and data clustered using average 
linkage, dendrograms are determined with pairwise Euclidean distance. Upper dendrogram 
highlights the separation of metabolomes of cells growing exponentially on minimal media, 
compared to the rich medium condition and non-growing cells (stationary 1d/2d). In the rich 





























Figure S12: Comparison of absolute intracellular concentrations of metabolites with literature 
data. Only for conditions analyzed both in our study and in Bennett et al. 2009 (left) or and 
Kochanowski et al. 2017 (right). 
 
Figure S13: Comparison of growth rates for conditions analyzed both in our study and in 








 94   
 
Figure S14: Metabolites with the highest correlation between their concentrations and growth 
rates. Shown all conditions with exponential growth in minimal medium. IMP (inosine 
monophosphate) and CAIR (5-Amino-1-(5-phospho-D-ribosyl)imidazole) are both precursors in 





Figure S15: histogram representing correlation values between metabolite levels against the 
relative growth rate, data from Kochanowski et al. 2016. Correlations were plotted for all 
metabolites (27) which had a measured concentration among all 23 conditions. R2 indicates the 
squared Person correlation coefficient. The highest scoring metabolite is cAMP, which was 
found also in our data to be among metabolites with a tendency  to correlate with growth. 
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Figure S16: correlations between relative standard deviation (RSD) of amino-acids against the 
relative (A) fit of the raw signal peaks, (B) standard deviation between replicates and (C) the 
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Figure S17: Calibration curves for absolute metabolite concentration calculations. 10 different 
concentrations of standards were measured (blue dots), and sample metabolites (red dots) were 
calibrating by fitting the measured standards by linear regression. Regressions were performed 
























Plasmid Target Spacer Sequence 
1 E. coli YYdCas9 pgRNA accA CAATCGGCTGTTCAAAATCA 
2 E. coli YYdCas9 pgRNA acnB CACGCTCAGCTACGTGCTTA 
3 E. coli YYdCas9 pgRNA adk TGAGTCCCTTTCCCCGCGCC 
4 E. coli YYdCas9 pgRNA alaC TGCGCGTAAAGCGACGTTCA 
5 E. coli YYdCas9 pgRNA argA GTATTGATATAGGGAACCGAATGG 
6 E. coli YYdCas9 pgRNA argE TTTTTCATTGTTGACACACCTC 
7 E. coli YYdCas9 pgRNA aroA AGCGATGGGTTGTAACGTCA 
8 E. coli YYdCas9 pgRNA aroL CCCGAGGCCCGATCAGAAAAAG 
9 E. coli YYdCas9 pgRNA asd AACCATGCGTTGCATGAGAA 
10 E. coli YYdCas9 pgRNA asnA ACGTTGTTTGGCAATGTAAG 
11 E. coli YYdCas9 pgRNA aspC  AATCGGGTCGGCAGGAGCGG 
12 E. coli YYdCas9 pgRNA bioA CCAGATATGGCGTTGGTCAA 
13 E. coli YYdCas9 pgRNA bioH ATGAACATTCCCCTGACCTT 
14 E. coli YYdCas9 pgRNA carA TATGGCCCGACCGTGAAACT 
15 E. coli YYdCas9 pgRNA coaA TTGCGGTCAAACTGTAGGTA 
16 E. coli YYdCas9 pgRNA coaD GTAATGGGATCGAAAGTACC 
17 E. coli YYdCas9 pgRNA cyaA GTTTCAGAGTCTCAATATAG 
18 E. coli YYdCas9 pgRNA cysE CAGTCCGCCAGCGTTCTGGCTT 
19 E. coli YYdCas9 pgRNA cysH CAGGGCGTTTAGATCGAGTT 
20 E. coli YYdCas9 pgRNA dapB CGGCTCCCGCGATGGCAACG 
21 E. coli YYdCas9 pgRNA dapD ATCTCGGCACGGCGTTCAAAAG 
22 E. coli YYdCas9 pgRNA dfp GAACGATTTTTTTACCGGCC 
23 E. coli YYdCas9 pgRNA dxr CGAGCCGGTCGAGCCCAGAA 
24 E. coli YYdCas9 pgRNA dxs CAGTGCCAGGGTCGGGTATT 
25 E. coli YYdCas9 pgRNA eno ACCGATGATTTTTACGATTT 
26 E. coli YYdCas9 pgRNA fbaA TCATCACCAGTGATTACGCC 




28 E. coli YYdCas9 pgRNA gadA ACGTGAATCGAGTAGTTCTGAG 
29 E. coli YYdCas9 pgRNA gadB ACGTTTTGATTCTGCGATAG 
30 E. coli YYdCas9 pgRNA gapA GGAAAACAATGCGACCGATA 
31 E. coli YYdCas9 pgRNA gdhA CGCGCTTTTGGACATGGTTG 
32 E. coli YYdCas9 pgRNA glmS CAGACGACGTAAACCTTCAAGA 
33 E. coli YYdCas9 pgRNA glnA CATCGTCAGTACGTGTTCAG 
34 E. coli YYdCas9 pgRNA gltA AACAGCTGTATCCCCGTTGA 
35 E. coli YYdCas9 pgRNA glyA CCACAGTTCGGCATCATAAT 
36 E. coli YYdCas9 pgRNA gmk GGATTTACCCGCGCCACTGG 
37 E. coli YYdCas9 pgRNA gnd GACTACGCCGATCTGTTGCT 
38 E. coli YYdCas9 pgRNA gpsA CAGTCATTGAAGCATTACGT 
39 E. coli YYdCas9 pgRNA gshB GATGTTGATGTTTGCGATG 
40 E. coli YYdCas9 pgRNA guaB CGGTAGAGTGAGCAGGAACG 
41 E. coli YYdCas9 pgRNA hemB TGCGCAGGCGACGAGGGCGT 
42 E. coli YYdCas9 pgRNA hemG CAGTTCCGAAGCCAGGTAGG 
43 E. coli YYdCas9 pgRNA hemH CAGGTTTGCCAGCAGGATAC 
44 E. coli YYdCas9 pgRNA hisB TCACTCGGCGGTTCGCTAATCA 
45 E. coli YYdCas9 pgRNA hisG TGAGTCATCACTTAAACGGC 
46 E. coli YYdCas9 pgRNA icd GTGATCTTCTTGCCTTGTGC 
47 E. coli YYdCas9 pgRNA idi TACTTTTCCAGCGTACCCGT 
48 E. coli YYdCas9 pgRNA ilvA CCTTCCGGAGCACCGGACAG 
49 E. coli YYdCas9 pgRNA ilvC CGCGCCATCGGCGAATTCATCG 
50 E. coli YYdCas9 pgRNA ispB AACACCCGCCATATCTTGCG 
51 E. coli YYdCas9 pgRNA ispG TTCTACGTTGAATTGGAGCC 
52 E. coli YYdCas9 pgRNA ispH AACCACGCGGGTTGGCCAAC 
53 E. coli YYdCas9 pgRNA ispU GCTGGCAATTTTTCGCTAAG 
54 E. coli YYdCas9 pgRNA kdsA CGCCAAACAGTACGAACGGC 
55 E. coli YYdCas9 pgRNA leuA GCCTGTTCACCGTCGCGCAATG 
56 E. coli YYdCas9 pgRNA LuxS CGACTGTGAAGCTATCTAACAA 




58 E. coli YYdCas9 pgRNA lysA TCGGTGCTGAACAGTGAATG 
59 E. coli YYdCas9 pgRNA menD GAATGACCGCCGCCCAGCGT 
60 E. coli YYdCas9 pgRNA metA AGCTCGTCCGGCACACGAAT 
61 E. coli YYdCas9 pgRNA metC ATTACGTGTCGCGTGTTTTT 
62 E. coli YYdCas9 pgRNA metE CAGGCCAACGCGAGGGAAACCG 
63 E. coli YYdCas9 pgRNA metK GGATGCCCTTCAGAGACGGACT 
64 E. coli YYdCas9 pgRNA nadA GGAAAGGATAAATCGCCGTGTC 
65 E. coli YYdCas9 pgRNA nadB ACACGTCACATGAATGTTCA 
66 E. coli YYdCas9 pgRNA nadC TCAGGGTTATAGCGGCGAGG 
67 E. coli YYdCas9 pgRNA nadE TCCTCTTCAGCATTAATCTG 
68 E. coli YYdCas9 pgRNA nadK TCAGTGCAGTGGGGTGCCGT 
69 E. coli YYdCas9 pgRNA nrdA TGCCGCCCAATCCAGAACGCGA 
70 E. coli YYdCas9 pgRNA pabA AATCGTAGTTATCTATAAGC 
71 E. coli YYdCas9 pgRNA panC TTGCTGACGCAGCAGCGGCA 
72 E. coli YYdCas9 pgRNA panD CATGAGTCACTTTCACGCGG 
73 E. coli YYdCas9 pgRNA pck  ATAAGCCTCGAGTTCTTGCG 
74 E. coli YYdCas9 pgRNA pfkA CGAATTGCGGCGTTCATGCC 
75 E. coli YYdCas9 pgRNA pfkB ATTGTTGCGCTATCGAGAGA 
76 E. coli YYdCas9 pgRNA pgi TGCCAGGCAGCGGTCTGCGT 
77 E. coli YYdCas9 pgRNA pgk TTTCCCAGCAAGATCCAGAT 
78 E. coli YYdCas9 pgRNA pheA TTTCTCTCGCAGCGCCAGTAAC 
79 E. coli YYdCas9 pgRNA ppc ACTGACATTACTACGCAATG 
80 E. coli YYdCas9 pgRNA proB GCCGAGTTTTACCACCAGCGTC 
81 E. coli YYdCas9 pgRNA proC GGCAATCAGACCGCCGAGAA 
82 E. coli YYdCas9 pgRNA prs CCAGCAAAAAGCTTCATATC 
83 E. coli YYdCas9 pgRNA ptsH  CGGTAATGGTAACTTCTTGC 
84 E. coli YYdCas9 pgRNA ptsI TTTACCGAAAGCGATACCCG 
85 E. coli YYdCas9 pgRNA purA TTTACCTTCGTCACCCCATT 
86 E. coli YYdCas9 pgRNA purB ACAGGGGAAACGGCGGTCAGTG 




88 E. coli YYdCas9 pgRNA purE GACACGCGCCGGATTATTGC 
89 E. coli YYdCas9 pgRNA purL ATTCGGAATGCCGACAGTGC 
90 E. coli YYdCas9 pgRNA pykA TTTTGTTCTGCGAAGCCTTC 
91 E. coli YYdCas9 pgRNA pykF TCCGATGGTGCAAACAATTT 
92 E. coli YYdCas9 pgRNA pyrB AAATGATATGTTTCTGATATAG 
93 E. coli YYdCas9 pgRNA pyrC CGGATCTTTAATACCTGGGA 
94 E. coli YYdCas9 pgRNA pyrD AAAGGGCTTTACGAACGAAG 
95 E. coli YYdCas9 pgRNA pyrE GCTAAGCGCAAATTCAATAAAC 
96 E. coli YYdCas9 pgRNA pyrF AGGAGAATTCGTAACAGCGC 
97 E. coli YYdCas9 pgRNA pyrG CAGAGAGGATACGACCCCGC 
98 E. coli YYdCas9 pgRNA ribA GCCCCATGGGGTTGGCAGTT 
99 E. coli YYdCas9 pgRNA ribB TTCGAAAGGCGTACCAAAAG 
100 E. coli YYdCas9 pgRNA ribC GTCAATCGACACCAGTTTTG 
101 E. coli YYdCas9 pgRNA sdhC GTCTGTAGGTCCAGATTAAC 
102 E. coli YYdCas9 pgRNA serA GAAGGCTTTCCAGCGCCTTT 
103 E. coli YYdCas9 pgRNA sucA GAGGTAAGAAGAGTCCAACC 
104 E. coli YYdCas9 pgRNA sucC CGGTGCTGGTAAGCCATAGC 
105 E. coli YYdCas9 pgRNA thyA AAAGCGTTCCGGTTCCGGTA 
106 E. coli YYdCas9 pgRNA tktA ATTGGCAAGCTCTTTACGTG 
107 E. coli YYdCas9 pgRNA tpiA  TTCCAGTTACCCATCACTAA 
108 E. coli YYdCas9 pgRNA trpA TTCTTTGCGCTCCTTCAACT 
109 E. coli YYdCas9 pgRNA tyrA ATCAATTTGATCGCGTAATG 
110 E. coli YYdCas9 pgRNA ubiD GCGTAAATCGTTATATTTCA 
111 E. coli YYdCas9 pgRNA zwf AATGACCAGGTCACAGGCCT 
 
pgRNA-bacteria plasmids for strains 4, 11, 29, 47, 72, 82, 105, 106 were cloned by Gibson 








Table S2: Occurrence of growth phenotypes at different starting optical densities (ODs). Data 
shown for three different YYdCas9 strains with gRNAs targeting purM (purine biosynthesis), argE 
and argA (arginine biosynthesis). Reported are the average (n=3) initial cell concentrations, the 
final OD at the time of occurrence of a growth defect, the time of occurrence of the defect and 
the number of OD duplications from the start of the culture.  
 
PurM 
Initial OD Final OD  Response Time Duplications 
0.08 0.1984 2.321 2.48 
0.038 0.0935 2.488 2.46 
0.021 0.0628 2.821 2.99 
ArgE 
Initial OD Final OD  Response Time Duplications 
0.082 0.216 2.321 2.63 
0.038 0.107 2.321 2.81 
0.0198 0.055 2.321 2.77 
ArgA 
Initial OD Final OD  Response Time Duplications 
0.0857 0.2616 2.321 3.05 
0.0405 0.1312 2.488 3.24 




Table S3: Correlation between metabolite concentrations and growth rates in different 




















Table S4: SVD of the metabolomics and proteomics datasets. The table displays, for each of 
the 14 singular vectors computed and the relative dataset, the correlation of each component 
to the growth rate values and how much each component contributes to explain the variance 
in the data. In bold, the 2 components for each dataset that had the highest correlation with 
the growth rate. 
 
proteome dataset metabolome dataset 
component R2 % variance R2 % variance 
SV1 0.88 73.78 0.12 59.50 
SV2 0.40 4.44 0.21 7.53 
SV3 0.07 3.10 0.41 5.31 
SV4 0.36 2.54 0.12 4.20 
SV5 0.07 2.05 0.02 3.88 
SV6 0.01 2.03 0.10 3.18 
SV7 0.00 1.86 0.02 2.95 
SV8 0.00 1.74 0.01 2.72 
SV9 0.01 1.64 0.01 2.48 
SV10 0.03 1.63 0.01 2.07 
SV11 0.00 1.54 0.05 1.95 
SV12 0.01 1.34 0.00 1.66 
SV13 0.00 1.26 0.01 1.34 


















Table S5: strains and reagents 
REAGENT or RESOURCE Source IDENTIFIER 
Bacterial and Virus Strains 
NEB® 5-alpha Competent 
E. coli: fhuA2 Δ(argF-
lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 
hsdR17 




























Baba et al. 2006 JW3400-1 
Genotypes and spacer 
sequences of arrayed 
CRISPRi strains are listed 
in Table S7. 
  
Chemicals,Peptides, and Recombinant Proteins 
Acetonitrile Honeywell Riedel-de Haën Cat#14261-2L 
Methanol VWR Cat#83638.320 
Anhydrotetracycline Sigma-Aldrich Cat#1035708-25MG 
IPTG Roth Cat#CN08.2 
Ampicillin Roth Cat#K029.2 
Kanamycin Roth Cat#T832.3 







Thermo Fisher Scientific Cat#23275 
PierceTM BCA Protein 
Assay Kit 
Thermo Fisher Scientific Cat#23225 
Recombinant DNA 




Zaslaver et al. 2006 N/A 
pUA66-PmetB-gfp: 
pPmetB-gfp 
Zaslaver et al. 2006 N/A 
Software and Algorithms   
Matlab R2018b 
(9.5.0.944444) for 
analysis of experimental 
data 
mathworks.com N/A 
Python 3.7.4 python.org N/A 
COBRApy opencobra.github.io/cobrapy N/A 
Progenesis QIP (Waters) waters.com N/A 























Table S6: oligonucleotides. 




Amplification of pgRNA for Gibson Assembly with 






Amplification of pgRNA for Gibson Assembly with 
amplified spacer oligonucleotides  








Amplification of spacer oligonucleotide This study  

















Amplification of the pgRNA backbone for Gibson 
Assembly with amplified pooled oligonucleotides  




Amplification of the pgRNA backbone for Gibson 
Assembly with amplified pooled oligonucleotides  





Amplification of a 300 bp fragment of pgRNA 
including the sgRNA  





Amplification of a 300 bp fragment of pgRNA 
including the sgRNA  



































I5 oligo This study  
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